Invited review IRSp53 / BAIAP2 in dendritic spine development , NMDA receptor regulation , and psychiatric disorders Jaeseung Kang a , 1 , Haram Park a , 1 , Eunjoon Kim a , b , * a Department of Biological Sciences , Korea Advanced Institute of Science and Technology ( KAIST ) , Daejeon 305 - 701 , South Korea b Center for Synaptic Brain Dysfunctions , Institute for Basic Science ( IBS ) , Daejeon 305 - 701 , South Korea a r t i c l e i n f o Article history : Received 2 June 2015 Received in revised form 26 June 2015 Accepted 28 June 2015 Available online 12 August 2015 Keywords : Dendritic spine Actin Membrane IRSp53 NMDA receptor Psychiatric disorders a b s t r a c t IRSp53 ( also known as BAIAP2 ) is a multi - domain scaffolding and adaptor protein that has been implicated in the regulation of membrane and actin dynamics at subcellular structures , including ﬁ lo - podia and lamellipodia . Accumulating evidence indicates that IRSp53 is an abundant component of the postsynaptic density at excitatory synapses and an important regulator of actin - rich dendritic spines . In addition , IRSp53 has been implicated in diverse psychiatric disorders , including autism spectrum dis - orders , schizophrenia , and attention de ﬁ cit / hyperactivity disorder . Mice lacking IRSp53 display enhanced NMDA ( N - methyl - D - aspartate ) receptor function accompanied by social and cognitive de ﬁ cits , which are reversed by pharmacological suppression of NMDA receptor function . These results suggest the hy - pothesis that defective actin / membrane modulation in IRSp53 - de ﬁ cient dendritic spines may lead to social and cognitive de ﬁ cits through NMDA receptor dysfunction . This article is part of the Special Issue entitled ‘ Synaptopathy e from Biology to Therapy ’ . © 2015 The Authors . Published by Elsevier Ltd . This is an open access article under the CC BY - NC - ND license ( http : / / creativecommons . org / licenses / by - nc - nd / 4 . 0 / ) . 1 . Introduction IRSp53 ( for insulin receptor substrate p53 ) , also known as BAIAP2 ( brain - speci ﬁ c angiogenesis inhibitor 1 - associated protein 2 ) , is a multi - domain adaptor protein originally identi ﬁ ed as a protein that is tyrosine phosphorylated by the insulin receptor and IGF - 1 ( insulin - like growth factor 1 ) receptor ( Yeh et al . , 1996 ) . Subsequent studies have ﬁ rmly established IRSp53 as an important regulator of membrane and actin dynamics at actin - rich subcellular structures , including ﬁ lopodia and lamellipodia ( Ahmed et al . , 2010 ; Scita et al . , 2008 ; Suetsugu et al . , 2010 ) . Although the functions of IRSp53 have been mainly studied in non - neural cells , steadilyaccumulating evidence supports neuronal functions of IRSp53 , in particular , in the regulation of membrane / actin dynamics at excitatory synapses and dendritic spines . The ﬁ rst such evidence was a report that identi ﬁ ed IRSp53 as an important component of the postsynaptic density ( PSD ) ( Abbott et al . , 1999 ) d multi - protein complexes in the postsynaptic side of excitatory synapses that couple receptor activation with downstream signaling ( Emes and Grant , 2012 ; Kennedy , 1993 ; Sheng and Hoogenraad , 2007 ; Sheng and Kim , 2011 ) . More recently , IRSp53 / BAIAP2 has been implicated in several psychiatric disorders , including autism spectrum disorders ( ASDs ) ( Celestino - Soper et al . , 2011 ; Levy et al . , 2011 ; Toma et al . , 2011 ) , schizophrenia ( Fromer et al . , 2014 ; Purcell et al . , 2014 ) , and atten - tion de ﬁ cit / hyperactivity disorder ( ADHD ) ( Liu et al . , 2013 ; Ribases et al . , 2009 ) . In parallel , neurobiological studies on mice lacking IRSp53 ( IRSp53 (cid:1) / (cid:1) mice ) have revealed that IRSp53 deletion leads to synaptic and behavioral abnormalities that are reminiscent of symptoms of IRSp53 - related psychiatric disorders , suggesting the possibility of IRSp53 - related synaptopathies . In this review , wewill summarize the reported roles of IRSp53 in the regulation of membrane / actin dynamics , dendritic spine development , NMDA receptor ( NMDAR ) function , and social and cognitive behaviors . In addition , we will discuss how the deletion of the IRSp53 gene leads to enhanced NMDA ( N - methyl - D - aspartate ) receptor ( NMDAR ) function , which is associated with social and cognitive de ﬁ cits in IRSp53 (cid:1) / (cid:1) mice . 2 . Domain structure of IRSp53 The IRSp53 gene is located at human chromosome 17q25 and mouse chromosome 11E2 . These genes are predicted to consist of * Corresponding author . Center for Synaptic Brain Dysfunctions , Institute for Basic Science ( IBS ) , Daejeon 305 - 701 , South Korea . E - mail address : kime @ kaist . ac . kr ( E . Kim ) . 1 These authors contributed equally to the work . Contents lists available at ScienceDirect Neuropharmacology journal homepage : www . elsevier . com / locate / neuropharm http : / / dx . doi . org / 10 . 1016 / j . neuropharm . 2015 . 06 . 019 0028 - 3908 / © 2015 The Authors . Published by Elsevier Ltd . This is an open access article under the CC BY - NC - ND license ( http : / / creativecommons . org / licenses / by - nc - nd / 4 . 0 / ) . Neuropharmacology 100 ( 2016 ) 27 e 39 17 and 16 exons , respectively ( Miyahara et al . , 2003 ) . The IRSp53 protein contains multiple domains for protein e - protein interactions , including an IMD ( IRSp53 - MIM homology domain ; also known as an I - BAR ) domain , a CRIB - PR ( Cdc42 / Rac interactive binding - proline rich ) domain , an SH3 ( Src homology 3 ) domain , a WW domain , a WH2 ( WASP homology 2 ) domain , and a C - terminal PDZ - B ( PSD - 95 / Dlg / ZO - 1 domain - binding ) motif ( Fig . 1A ) . The IMD / I - BAR domain is known to bind to and deform the plasma membrane , creating a negative membrane curvature ( Suetsugu et al . , 2010 ) . IRSp53 shares a similar domain structure , with the exception of the CRIB - PR domain ( Yamagishi et al . , 2004 ) , with two other members of the IRSp53 subfamily of IMD - containing proteins : IRTKS ( insulin receptor tyrosine kinase substrate ; also known as BAIAP2L1 ) , which is minimally expressed in the brain ( Millard et al . , 2007 ) , and FLJ22582 ( BAIAP2L2 ) , which has been minimally stud - ied ( Yamagishi et al . , 2004 ) . Drosophila and Caenorhabditis elegans also have proteins with a similar domain structure ( Yamagishi et al . , 2004 ) . Alternative splicing generates a total of ﬁ ve splice variants of IRSp53 , four in humans and three in mice , four of which d S , L , M , and T forms d mainly differ in the C - terminal region , sharing the ﬁ rst 511 aa residues , whereas the ﬁ fth , termed the B form here ( IRSp53 - B ) , lacks ~ 40 aa in the CRIB - PR domain ( Alvarez and Fig . 1 . Domain structure , splice variants , and activation mechanisms of IRSp53 . ( A ) Domain structure and splice variants identi ﬁ ed in humans and mice . Note that the splice variations are mainly observed in C - terminal regions , except for the B form in mice lacking a part of the CRIB - PR domain . IMD , IRSp53 - MIM homology domain ; CRIB - PR , Cdc42 / Rac interactive binding - proline rich domain ; SH3 , Src homology 3 domain ; WW , WW domain ; PDZ - B , PSD - 95 / Dlg / ZO - 1 domain - binding motif ; WH2 , WASP homology 2 domain . ( B ) Autoinhibition andactivationmechanismsinIRSp53 . Head - to - head dimersof IRSp53 areautoinhibited inaclosed conformation throughan intramolecular interactioninvolvingthe CRIB - PR and SH3 domains . Binding of activated ( GTP - bound ) Cdc42 to the CRIB - PR domain opens up the protein , allowing the SH3 domain to bind downstream effectors such as N - WASP and WAVE2 . J . Kang et al . / Neuropharmacology 100 ( 2016 ) 27 e 39 28 Williams , 1998 ; Govind et al . , 2001 ; Miyahara et al . , 2003 ; Oda et al . , 1999 ; Okamura - Oho et al . , 1999 ) . These variants could be func - tionally distinct because the S and L forms are phosphorylated by insulin stimulation , whereas the T form is phosphorylated by IGF - 1 stimulation ( Okamura - Oho et al . , 2001 ) . There are two major IRSp53 protein species in rodent brains with apparent molecular masses of ~ 58 and 53 kDa . The molecular nature of these proteins is unclear , although they likely represent the S from with or without the 40 - aa splice insert in the CRIB - PR domain . In support of this possibility , immunoblotting and reverse transcription - polymerase chain reaction ( RT - PCR ) data indicate that the S variant is the main isoform expressed in rat cultured hippocampal neurons ( Hori et al . , 2005 ) . Both IRSp53 species coimmunoprecipitate with the excitatory postsynaptic PDZ protein PSD - 95 in rat brains ( Choi et al . , 2005 ; Soltau et al . , 2004 ) , suggesting that they both have the PDZ - B motif , which is present in the S form . In vitro protein translation of mouse S forms with or without the 40 - aa insert yields protein species of ~ 58 and 53 kDa ( Alvarez et al . , 2002 ) . Post - translational modi ﬁ cation is unlikely to account for the two bands , because the 5 kDa difference between them is unlikely to be caused by protein phosphorylation , and deglycosylation enzymes have no effect on the protein band sizes ( Abbott et al . , 1999 ) . Functionally , if the 58 and 53 kDa proteins differ in the CRIB - PR domain , they are likely to have distinct autoinhibitory mechanisms ( see below for details ) . 3 . Expression patterns of IRSp53 mRNAs and proteins Northern blot analyses indicate that IRSp53 is expressed most strongly in the brain , but also in other tissues , including the spleen , lung , liver , and testis ( Abbott et al . , 1999 ; Bockmann et al . , 2002 ) . In the brain , IRSp53 mRNAs are detected in regions including the cortex , hippocampus , striatum , and cerebellum ( Bockmann et al . , 2002 ) . At the protein level , IRSp53 expression , measured by X - gal staining of IRSp53 þ / (cid:1) mouse brain slices , is observed in regions including the cortex , hippocampus , striatum , and cerebellum ( Kim et al . , 2009a ; Sawallisch et al . , 2009 ) , a distribution pattern similar to that of the corresponding mRNA . In addition , Immunohisto - chemical analyses with speci ﬁ c IRSp53 antibodies indicate a similar distribution pattern of endogenous IRSp53 proteins in rat brains ( Bockmann et al . , 2002 ; Burette et al . , 2014 ) . 4 . Protein interactions of IRSp53 A role for IRSp53 in the regulation of membrane and actin dy - namics is supported by the fact that IRSp53 interacts with mem - branes , actin ﬁ laments , small GTPases , actin regulatory proteins , and PDZ domain - containing scaffolding proteins . Many of these proteins regulate neuronal / synaptic functions , and some have been implicated in brain disorders ( Table 1 ) . The N - terminal IMD domain binds and deforms PI ( 4 , 5 ) P 2 - and PI ( 3 , 4 , 5 ) P 3 - rich membranes through its I - BAR activity ( Mattila et al . , 2007 ; Suetsugu et al . , 2006 ) . In addition , the IMD domain of IRSp53 binds and bundles actin ﬁ laments ( Yamagishi et al . , 2004 ) , although its role in membrane deformation is unclear ( Safari and Suetsugu , 2012 ) . Two IMD domains form an anti - parallel dimer ( Millard et al . , 2005 ) , leading to the dimerization of full - length IRSp53 proteins in a head - to - head manner ( Fig . 1B ) . The CRIB - PR domain binds the GTP - bound ( activated ) form of the small GTPase Cdc42 ( Govind et al . , 2001 ; Krugmann et al . , 2001 ) . Because Cdc42 itself is tethered to the plasma membrane , both IMD and Cdc42 contribute to the membrane targeting of IRSp53 , in line with the concept that phosphoinositides and small GTPases act in synergy to recruit cytoplasmic proteins to speci ﬁ c compartments of the plasma membrane ( Di Paolo and De Camilli , 2006 ) . In the full - length IRSp53 protein , interaction of the SH3 domain with binding partners is thought to be inhibited through an intra - molecular interaction involving the CRIB - PR and SH3 domains ( Alvarez et al . , 2002 ; Disanza et al . , 2006 ; Kast et al . , 2014 ) . This autoinhibition of IRSp53 is relieved by Cdc42 binding to the CRIB - PR domain ( Alvarez et al . , 2002 ; Govind et al . , 2001 ; Kast et al . , 2014 ; Krugmann et al . , 2001 ) , allowing the SH3 domain to bind its effectors . Many of these effectors are actin modulatory proteins such as WAVE - 2 , N - WASP , Eps8 , Ena / VASP , and mDia1 , which in many cases converge onto the Arp2 / 3 complex ( Table 1 ) , known to promote nucleation of branched actin ﬁ lament networks ( Scita et al . , 2008 ) . The autoinhibition of IRSp53 also suppresses the interaction of the IMD domain with membranes , as supported by the limited localization of the autoinhibited protein in the plasma membrane ( Kast et al . , 2014 ) . In addition to regulating actin dynamics , the SH3 effectors of IRSp53 enhance additional opening / activation of IRSp53 . For instance , dual binding of Cdc42 and SH3 effectors such as Eps8 ( Funato et al . , 2004 ) , to IRSp53 synergistically induces full opening / activation of IRSp53 ( Disanza et al . , 2006 ; Kast et al . , 2014 ) . WAVE - 2 binding to the SH3 domain enhances Rac1 binding to the IMD domain ( Miki and Takenawa , 2002 ; Miki et al . , 2000 ) . In addition , some SH3 effectors such as Tiam1 ( a guanine nucleotide exchange factor or GEF for Rac ) and Eps8 ( coupled to Sos - 1 and Abi - 1 , both with Rac - GEF activities ) activate Rac1 ( Connolly et al . , 2005 ; Funato et al . , 2004 ) , suggesting that IRSp53 can act both upstream and downstream of Rac . These mechanisms are thought to contribute to IRSp53 - dependent formation of actin - rich protrusive structures such as ﬁ lopodia ( Govind et al . , 2001 ; Krugmann et al . , 2001 ; Yamagishi et al . , 2004 ) and lamellipodia ( Miki et al . , 2000 ) at the interface of membranes and actin ﬁ laments . The WH2 domain is generally known to bind monomeric actin , but the WH2 domain in IRSp53 is dissimilar to canonical WH2 domains , and thus its function is unclear ( Scita et al . , 2008 ) . Lastly , the C - terminal PDZ - binding ( PDZ - B ) motif interacts with diverse PDZ domain - containing scaffolding proteins , including PSD - 95 , PSD - 93 / Chapsyn - 110 , and MALS / LIN - 7 ( Choi et al . , 2005 ; Hori et al . , 2003 ; Soltau et al . , 2004 ) . 5 . Synaptic localization of IRSp53 Since the identi ﬁ cation of IRSp53 as a core component of the PSD and excitatory synapses ( Abbott et al . , 1999 ) , additional experimental evidence has supported the excitatory synaptic localization of IRSp53 . For instance , in situ hybridization and immunoblot analyses of biochemical rat brain fractions indicate that IRSp53 expression is signi ﬁ cantly increased during the ﬁ rst 3 weeks of postnatal brain development ( Bockmann et al . , 2002 ; Choi et al . , 2005 ) , during which active synaptogenesis occurs . Ultrastructural electron microscopy ( EM ) indicates that IRSp53 proteins are present in the PSD as well as at other sub - regions of dendritic spines such as tangential walls and spine cytosolic regions ( Choi et al . , 2005 ) . A more recent EM study reported that IRSp53 displays distinct distribution patterns within the PSD in different brain regions . In spiny excitatory neurons of the neocortex and hippocampus , IRSp53 is concentrated in the center of the PSD rather than in the periphery , whereas it is uniformly distributed along the lateral axis of the PSD in spiny inhibitory neurons of the neostriatum and cerebellar cortex ( Burette et al . , 2014 ) . The reasons for these differences are unclear . Synaptic localization of IRSp53 appears to be regulated by neuronal activity . NMDA receptor stimulation in cultured hippo - campal neurons promotes synaptic localization of IRSp53 in a manner requiring protein kinase C activation , the IMD and PDZ - B J . Kang et al . / Neuropharmacology 100 ( 2016 ) 27 e 39 29 Table 1 Binding partners of IRSp53 and their neuronal / synaptic functions and associations with brain disorders . Domain Binding partner Function of interaction Partner ' s neuronal / synaptic function Partner ' s association with brain disorders IMD F - actin ( Yamagishi et al . , 2004 ) Actin bundling ( Yamagishi et al . , 2004 ) Main cytoskeleton in dendritic spines IRSp53 ( Millard et al . , 2005 ) Forms IRSp53 dimers ( Millard et al . , 2005 ) Actin and membrane dynamics in spines ( Scita et al . , 2008 ) ASD , schizophrenia , and ADHD ( See Table 3 for details ) Kank1 ( Roy et al . , 2009 ) Inhibits Rac1 - IRSp53 interaction ( Roy et al . , 2009 ) Suppresses actin ﬁ lament formation ( Kakinuma et al . , 2008 ) Cerebral palsy ( Lerer et al . , 2005 ) ASD , motor / cognitive dysfunctions ( Vanzo et al . , 2013 ) Rac1 ( Miki et al . , 2000 ) Links Rac1 and Wave ( Miki et al . , 1998 ; Miki et al . , 2000 ) Membrane deformation ( Suetsugu et al . , 2006 ) Neuronal development ( Govek et al . , 2005 ; Tolias et al . , 2011 ) CRIB - PR Cdc42 ( Govind et al . , 2001 ; Krugmann et al . , 2001 ) Relieves autoinhibition ( Krugmann et al . , 2001 ) Neuronal development ( Govek et al . , 2005 ; Tolias et al . , 2011 ) Between CRIB - PR and SH3 14 - 3 - 3 z ( Robens et al . , 2010 ) Inhibits IRSp53 binding to SH3 effectors and Cdc42 ( Robens et al . , 2010 ) Neural signaling , development , andprotection ( FooteandZhou , 2012 ) ASD ( Toma et al . , 2013 ) SH3 BAI1 ( Oda et al . , 1999 ) Localizes IRSp53 to membranes ( Oda et al . , 1999 ) Synaptogenesis and spine formation ( Stephenson et al . , 2014 ) BRAG1 / IQ - ArfGEF ( Sanda et al . , 2009 ) Regulate ARF signaling in dendritic spines ( Sanda et al . , 2009 ) Synaptic plasticity ( Myers et al . , 2012 ) Intellectual disability ( Shoubridge et al . , 2010 ) Cypin ( BarilariandDente , 2010 ) Form the CIPP - Cypin - IRSp53 complex ( Barilari and Dente , 2010 ) Microtubules and dendrite patterning ( Tseng and Firestein , 2011 ) DRPLA / Atrophin - 1 ( Okamura - Oho et al . , 1999 ) May regulate insulin / IGF - 1 signaling pathways ( Okamura - Oho et al . , 1999 ) Transcriptional co - repressor ( Shen and Peterson , 2009 ) DRPLA ( Tsuji , 2012 ) Dynamin1 ( Chou et al . , 2014 ) Promotes ﬁ lopodia formation ( Chou et al . , 2014 ) Membrane ﬁ ssion during endocytosis ( Ferguson and De Camilli , 2012 ) Epilepsy ( Ferguson and De Camilli , 2012 ) Eps8 ( Funato et al . , 2004 ) Activates IMD - bound Rac ( Funato et al . , 2004 ) Dendritic spines ( Menna et al . , 2013 ; Stamatakou et al . , 2013 ) ASD ( Menna et al . , 2013 ) Espin ( Sekerkova et al . , 2003 ) Regulates actin binding and bundling ( Sekerkova et al . , 2003 ) Stereociliary actin bundle ( Sekerkova et al . , 2011 ) . Deafness , vestibular dysfunction ( Naz et al . , 2004 ) mDia1 ( Fujiwara et al . , 2000 ) Promotes ﬁ lopodia formation ( Goh et al . , 2012 ) Migration of interneuron precursors ( Shinohara et al . , 2012 ) Mena ( Krugmann et al . , 2001 ) Induces ﬁ lopodia formation ( Krugmann et al . , 2001 ) Neuronal polarity ( Drees and Gertler , 2008 ; Neukirchen and Bradke , 2011 ) Links gephyrin to actin ( Bausen et al . , 2006 ; Giesemann et al . , 2003 ) N - WASP ( Lim et al . , 2008 ) Promotes ﬁ lopodia formation ( Lim et al . , 2008 ) Neurite and spine development ( Irie and Yamaguchi , 2004 ; Suetsugu et al . , 2002 ; Wegner et al . , 2008 ) SH2B1 ( Hong et al . , 2014 ) Promotes ﬁ lopodia formation ( Hong et al . , 2014 ) Dendrite formation and branching ( Chen et al . , 2015 ) Developmental delay ( Bachmann - Gagescu et al . , 2010 ) Shank1 ( Soltau et al . , 2002 ) LinksShank1toCdc42andPSD - 95 ( Choi et al . , 2005 ; Soltau et al . , 2002 ) Spine morphology and synaptic function ( Sala et al . , 2001 ) ASD ( Leblond et al . , 2014 ; Sato et al . , 2012 ) Schizophrenia ( Lennertz et al . , 2012 ) Shank3 ( Bockmann et al . , 2002 ) Induces ﬁ lopodia outgrowth in neuronal cell lines ( Bockmann et al . , 2002 ) Dendritic spines ( Roussignol et al . , 2005 ) ASD , Phelan - McDermid syndrome , schizophrenia , bipolar , hyperkinetic ( Guilmatre et al . , 2014 ; Han etal . , 2013 ; Leblondetal . , 2014 ) Spin90 ( Teodorof et al . , 2009 ) Regulates Rac / Rho and actin ﬁ laments ( Teodorof et al . , 2009 ) Dendritic spines ( Cho et al . , 2013 ; Kim et al . , 2009b ; Wagner et al . , 2013 ) Synaptopodin ( Yanagida - Asanuma et al . , 2007 ) InhibitCdc42andMenabinding to IRSp53 ( Yanagida - Asanuma et al . , 2007 ) Spine apparatus and spine plasticity ( Korkotian et al . , 2014 ) Tiam1 ( Connolly et al . , 2005 ) Contributes to Rac signaling speci ﬁ city ( Connolly et al . , 2005 ) Spine development ( Tolias et al . , 2005 ; Tolias et al . , 2007 ) J . Kang et al . / Neuropharmacology 100 ( 2016 ) 27 e 39 30 domains of IRSp53 , and protein kinase C - dependent phosphoryla - tion of the IMD domain ( Hori et al . , 2005 ) . 6 . IRSp53 in dendritic spine development Dendritic spines , protrusions in neurons with distinct mem - brane curvatures in sub - regions ( i . e . head , wall , and neck ) , are well known for their actin - rich cytoskeleton ( Cingolani and Goda , 2008 ; Harris and Weinberg , 2012 ; Penzes and Rafalovich , 2012 ; Sala and Segal , 2014 ; Tada and Sheng , 2006 ) . Therefore , IRSp53 , a regulator of membrane and actin dynamics , could be expected to play a role in the regulation of dendritic spine development and plasticity . Dendritic spines contain a branched actin ﬁ lament network in the head , and a network of branched and linear actin ﬁ laments in the spine neck and in dendritic ﬁ lopodia ( a possible precursor of dendritic spines ) , which are reported to contain tightly bundled actin ﬁ laments ( Korobova and Svitkina , 2010 ) . These authors sug - gest that an actin patch on the dendritic trunk elongates into a ﬁ lopodium , and the tip expands into a mature spine head through the activity of the Arp2 / 3 complex , known to regulate dendritic spine structure and plasticity ( Kim et al . , 2013 , 2015 ) . Providing a more dynamic view of spine actin regulation , a recent study using single protein tracking and super - resolution imaging has revealed an interesting nanoscale sub - spine segrega - tion , where regulators of F - actin nucleation / branching such as IRSp53 and the WAVE complex are con ﬁ ned at the vicinity the PSD , whereas F - actin elongators such as VASP and formin - like protein - 2 move outwards from the PSD with protrusion tips ( Chazeau et al . , 2014 ) . This study also ﬁ nds that Rac1 reaches the PSD through membrane free - diffusion and is immobilized at the PSD depending on its levels of activation , whereas the Arp2 / 3 complex reaches to the PSD through cytosolic free - diffusion . Moreover , conditions promoting spine enlargement such as constitutively active Rac1 , or overexpressed Shank3 , delocalize the WAVE complex from the PSD , and translocate the complex to the other parts of the spine to promote F - actin elongation throughout the spine . Overexpression of IRSp53 in dissociated cultured hippocampal neurons increases spine density and size ( Choi et al . , 2005 ) . Knockdown of IRSp53 decreases spine density , but not spine size ( Choi et al . , 2005 ) . Similar to these results , excitatory synapses develop slowly in dissociated hippocampal neurons derived from IRSp53 (cid:1) / (cid:1) mice ( Sawallisch et al . , 2009 ) . IRSp53 (cid:1) / (cid:1) mice display normal densities of excitatory synapses and dendritic spines in the hippocampus ( Kim et al . , 2009a ; Sawallisch et al . , 2009 ) but reduced excitatory synapse and spine densities in the medial pre - frontal cortex ( Chung et al . , 2015 ) . This indicates distinct in ﬂ uences of IRSp53 deletion on different brain regions . Phenotypes of IRSp53 (cid:1) / (cid:1) mice are summarized in Table 2 . How might IRSp53 contribute to synaptogenesis ? The CRIB - PR domain of IRSp53 can bind to activated Cdc42 , which is tethered to the plasma membrane at sites of early synapses , promoting the membrane targeting and activation of IRSp53 . This would allow the IMD domain of IRSp53 bind to and deform PI ( 4 , 5 ) P 2 - and PI ( 3 , 4 , 5 ) P 3 - rich plasma membranes to generate protrusive structures ( Fig . 2 ) . Concurrent with this , the IMD domain may interact with and bundle ( or form a linear array of ) actin ﬁ laments at sites of membrane deformation . This physical connection of the plasma membrane and actin ﬁ laments , which may also occur in mature synapses , would require a large amount of IRSp53 protein . Consistent with this pos - sibility , IRSp53 is quite abundant in the PSD , where its levels are comparable to those of other scaffolding / adaptor proteins such as PSD - 95 , GKAP , Shank , and Homer ( Cheng et al . , 2006 ) . The SH3 domain of activated IRSp53 may also promote actin polymerization at sites of IRSp53 clustering in early and mature synapses in a neuronal activity - and Rac / Cdc42 - dependent manner ( Fig . 2 ) . SH3 effectors such as Eps8 , Ena / VASP , and mDia1 , acting downstream of Cdc42 , may drive the formation of linear actin ﬁ l - aments ( Ahmed et al . , 2010 ; Scita et al . , 2008 ) , while N - WASP and WAVE2 , acting downstream of Rac , may promote branched actin ﬁ laments . In direct support of an important role of the SH3 domain in spine regulation , a mutant IRSp53 with a point mutation in the SH3 domain that abolishes effector binding , or a fragment of WAVE2 containing only the IRSp53 - SH3 - interacting proline - rich region , suppresses dendritic spine density in a dominant - negative manner when overexpressed in cultured hippocampal neurons ( Choi et al . , 2005 ) . In line with the critical roles of Cdc42 and Rac in IRSp53 - dependent spine development mentioned above , activation of NMDARs and EphB receptors are known to stimulate Rac / Cdc42 through mechanisms including calcium / calmodulin - dependent kinases I / II ( CaMKI / II ) and a variety of GEFs such as Kalirin - 7 , Tiam1 , GEFT , and a / b Pix ( ARHGEF6 / 7 ) ( Penzes and Cahill , 2012 ; Table 1 ( continued ) Domain Binding partner Function of interaction Partner ' s neuronal / synaptic function Partner ' s association with brain disorders VASP ( Disanza et al . , 2013 ) Promotes ﬁ lopodia formation ( Disanza et al . , 2013 ) Neuronal polarity ( Drees and Gertler , 2008 ; Neukirchen and Bradke , 2011 ) Wave - 1 ( Miki et al . , 2000 ) Links Rac and Wave ( Miki et al . , 1998 ; Miki et al . , 2000 ) Spines , synaptic plasticity , and memory ( Hazaietal . , 2013 ; Kim et al . , 2006 ; Soderling et al . , 2007 ) Wave - 2 ( Miki et al . , 2000 ) Links Rac and Wave ( Miki et al . , 1998 ; Miki et al . , 2000 ) Likely dendritic spines ( Choi et al . , 2005 ; Ito et al . , 2010 ; Lee etal . , 2006 ; SoderlingandScott , 2006 ) PDZ - B CIPP ( Alpi et al . , 2009 ; Barilari and Dente , 2010 ) Form the CIPP - Cypin - IRSp53 complex ( Barilari and Dente , 2010 ) Synaptic membrane protein clustering ( Kurschner et al . , 1998 ) ASD and Schizophrenia ( Kenny et al . , 2014 ) MALS / LIN - 7 ( Hori et al . , 2003 ) May translocate IRSp53 to cell e cell contacts ( Hori et al . , 2003 ) Synapse development and function ( Mizuno et al . , 2015 ) ASD ( Mizuno et al . , 2015 ) PSD - 93 ( Choi et al . , 2005 ) Synaptic localization of IRSp53 ( Choi et al . , 2005 ) Postsynapticproteinscaffolding ( Sheng and Kim , 2011 ) ASD ( Egger et al . , 2014 ) PSD - 95 ( Choietal . , 2005 ; Soltau et al . , 2004 ) Synaptic localization of IRSp53 ( Choi et al . , 2005 ) Postsynapticproteinscaffolding ( Sheng and Kim , 2011 ) ASD and William ' s syndrome ( Feyder et al . , 2010 ) Schizophrenia ( Balan et al . , 2013 ; Purcell et al . , 2014 ) J . Kang et al . / Neuropharmacology 100 ( 2016 ) 27 e 39 31 Table 2 Electrophysiological and behavioral phenotypes of IRSp53 (cid:1) / (cid:1) mice . Phenotypes of IRSp53 (cid:1) / (cid:1) mice Changes References Electrophysiological phenotypes AMPA - mEPSC in CA1 Normal ( Kim et al . , 2009a ) NMDA - mEPSC in CA1 Increased ( ampl . ) ( Kim et al . , 2009a ) PPF in DG in vivo Increased ( Sawallisch et al . , 2009 ) PPF in CA1 Increased ( Sawallisch et al . , 2009 ) NMDA / AMPA ratio in CA1 Increased ( Kim et al . , 2009a ) LTP in DG in vivo Increased ( Sawallisch et al . , 2009 ) LTP in CA1 Increased ( Kim et al . , 2009a ; Sawallisch et al . , 2009 ) LTD in CA1 Normal ( Kim et al . , 2009a ) mGluR - LTD in CA1 Normal ( Chung et al . , 2015 ) LTD of NMDAR EPSCs in CA1 Impaired ( Chung et al . , 2015 ) AMPA - mEPSC in mPFC Decreased freq . & ampl . ( Chung et al . , 2015 ) Firing rate in mPFC in vivo Decreased ( Chung et al . , 2015 ) Behavioral phenotypes Open ﬁ eld locomotion Normal ; Hyperactive ( Sawallisch et al . , 2009 ) ; ( Chung et al . , 2015 ) Rotarod motor function Normal ( Sawallisch et al . , 2009 ) Contextual fear Increased ( Sawallisch et al . , 2009 ) Morris water maze memory Impaired ( Kim et al . , 2009a ) Novel object recognition Impaired ( Kim et al . , 2009a ) 3 - chamber social interaction Decreased ( Chung et al . , 2015 ) USV calls ( to female ) Decreased ( Chung et al . , 2015 ) Fig . 2 . A model for the proposedroles of IRSp53 in the development of dendritic spines . IRSp53 likely binds to and deforms the dendritic plasma membrane through the N - terminal IMDdomain , producinga protrusivestructure ( membrane deformation ) . Once the activated ( GTP - bound ) form of Cdc42 , which acts inthe downstream of membrane proteinssuch as NMDARs , binds to and opens up IRSp53 , IRSp53 will interact with and recruit diverse actin modulatory SH3 effectors . Effectors including Ena / VASP , mDia2 , and Eps8 may promote linearactin ﬁ lament formation ( linearactin ﬁ lament formation ) , likelydrivingthe elongationandbundlingof earlydendritic protrusions . Others such as WAVEand N - WASP , acting in the downstream of Rac , may drive the formation of branched actin ﬁ laments in relatively mature dendritic spines by acting on the Arp2 / 3 complex ( branched actin ﬁ lament for - mation ) . IRSp53 is also thought to bridge the plasma membrane and actin ﬁ laments in dendritic spines through its IMD domain ( actin - membrane bridge ) . The dual interaction of IRSp53 with the excitatory postsynaptic scaffolds PSD - 95 and Shank may allow the formation of tighter and bigger structural and signaling complexes . J . Kang et al . / Neuropharmacology 100 ( 2016 ) 27 e 39 32 Penzes et al . , 2008 ; Sala and Segal , 2014 ; Saneyoshi and Hayashi , 2012 ; Tolias et al . , 2011 ) . Conversely , Rac / Cdc42 activities can be suppressed by diverse GTPase activating proteins ( GAPs ) , including intersectin , a 1 - chimaerin , Bcr / Abr , SRGAP2 / 3 , and RhoGAP2 , balancing the actions of Rac GEFs . The C - terminal PDZ - binding motif of IRSp53 binds to the PDZ domains of the excitatory postsynaptic scaffolds PSD - 95 and PSD - 93 / Chapsyn - 110 ( Choi et al . , 2005 ; Soltau et al . , 2004 ) , in - teractions that appear to promote synaptic localization of IRSp53 ( Choi et al . , 2005 ; Hori et al . , 2005 ) ( Fig . 2 ) . Conversely , IRSp53 may also recruit and stabilize PSD - 95 at sites of early synaptic pro - trusions or mature dendritic spines where membrane deformation and actin polymerization / stabilization is occurring . IRSp53 may also form a ternary complex with PSD - 95 and Shank ( Soltau et al . , 2004 ) , leading to the formation of a bigger scaffolding / signaling complex in the PSD . Given that the SH3 domain of IRSp53 can interact with diverse actin - regulatory proteins , it will be important to understand how various SH3 effectors cooperate with Rac / Cdc42 and IRSp53 to regulate the dynamics of branched and linear actin ﬁ laments dur - ing different stages of spine development and at multiple sub - spine domains . In addition , the types of SH3 effectors bound to IRSp53 and their phosphorylation states determine the direction and rate of actin ﬁ lament growth during ﬁ lopodia formation ( Ahmed et al . , 2010 ) . It is therefore conceivable that synaptic receptors and associated signaling pathways acting upstream of IRSp53 may further coordinate IRSp53 - dependent spine regulation . 7 . IRSp53 in the regulation of excitatory synaptic transmission and plasticity Given the importance of the actin cytoskeleton and its dynamics in the regulation of excitatory synaptic transmission and plasticity ( Calabrese et al . , 2006 ; Cingolani and Goda , 2008 ; Hotulainen and Hoogenraad , 2010 ; Oertner and Matus , 2005 ; Penzes and Rafalovich , 2012 ; Sala and Segal , 2014 ; Saneyoshi and Hayashi , 2012 ; Tada and Sheng , 2006 ) , IRSp53 deletion in neurons could be expected to modify synaptic functions . Indeed , overexpression of IRSp53 , or a mutant form of IRSp53 that lacks the SH3 domain and is constitutively targeted to excit - atory synapses , in cultured hippocampal neurons increases the amplitude of miniature excitatory postsynaptic currents ( mEPSCs ) ( Hori et al . , 2005 ) , suggesting that IRSp53 positively regulates excitatory synaptic transmission . In contrast to these in vitro re - sults , IRSp53 (cid:1) / (cid:1) Schaffer collateral - CA1 pyramidal synapses in the hippocampus show normal amplitude and frequency of mEPSCs , input e output relationship of basal transmission , and paired pulse facilitation ( PPF ) ( Kim et al . , 2009a ) ( summarized in Table 2 ) . Similar results were reported by another laboratory ( Sawallisch et al . , 2009 ) , although this latter study did ﬁ nd an increase in PPF . IRSp53 (cid:1) / (cid:1) synapses on dentate gyrus granule cells receiving inputs from the medial perforant pathway show unaltered basal trans - mission but increased PPF ( Sawallisch et al . , 2009 ) . Collectively , these results suggest that AMPA ( a - amino - 3 - hydroxy - 5 - methyl - 4 - isoxazolepropionic acid ) receptor ( AMPAR ) - mediated synaptic transmission is largely normal in the hippocampus . Intriguingly , however , NMDAR - mediated excitatory synaptic transmission is enhanced at IRSp53 (cid:1) / (cid:1) SC - CA1 synapses , as measured by pharmacologically isolated NMDAR - dependent mEPSCs and evoked EPSCs ( Kim et al . , 2009a ) . In addition , long - term potentiation ( LTP ) is markedly enhanced , although long - term depression ( LTD ) is unaffected . These results suggest that NMDAR function is selectively enhanced at IRSp53 (cid:1) / (cid:1) hippocampal synapses ( Kim et al . , 2009a ; Sawallisch et al . , 2009 ) . The IRSp53 (cid:1) / (cid:1) mPFC region shows changes distinct from those in the hippocampus ( Chung et al . , 2015 ) ( Table 2 ) . The frequency and amplitude of mEPSCs are markedly reduced in IRSp53 (cid:1) / (cid:1) prelimbic layer2 / 3 neurons , an effect that is paralleled by a decrease in excitatory synapse numbers , as shown by EM analysis . Unlike the case in the hippocampus , NMDAR function in the mPFC is unaltered , as measured by the NMDA / AMPA ratio . Therefore , the two IRSp53 (cid:1) / (cid:1) brain regions display distinct electrophysiological changes : the hippocampus shows a decrease in NMDAR function with no change in excitatory synapse numbers , whereas the mPFC displays normal NMDAR function but a decrease in excitatory synapse numbers . 8 . Mechanisms underlying NMDAR hyperactivity in IRSp53 ¡ / ¡ hippocampal neurons How might IRSp53 deletion lead to NMDAR hyperactivity in mice ? The molecular abundance and functional properties of NMDARs at excitatory synapses are determined by a large number of factors , including subunit composition , protein modi ﬁ cation , interacting proteins , and receptor traf ﬁ cking into and out of syn - apses ( Bard and Groc , 2011 ; Chen and Roche , 2007 ; Fan et al . , 2014 ; Horak et al . , 2014 ; Husi and Grant , 2001 ; Husi et al . , 2000 ; Lau and Zukin , 2007 ; Newpher and Ehlers , 2008 ; Paoletti et al . , 2013 ; Ryan et al . , 2008 ; Sanz - Clemente et al . , 2013 ) . Therefore , comprehen - sively identifying all underlying mechanisms would be a daunting task , but it is possible that there may be increased in ﬂ ux , or reduced ef ﬂ ux , of NMDARs at IRSp53 (cid:1) / (cid:1) synapses under basal conditions or during neuronal activity . Previous studies have shown that actin ﬁ laments are important for synaptic localization and activity of NMDARs as well as AMPARs ( Allison et al . , 1998 ; Bosch and Hayashi , 2012 ; Furukawa et al . , 1997 ; Rosenmund and Westbrook , 1993 ; Wyszynski et al . , 1997 ) . Consistent with this idea , actin ﬁ laments in IRSp53 (cid:1) / (cid:1) hippocampal neurons are abnormally stable , exhibiting resistance to NMDA - induced dispersal ( Chung et al . , 2015 ) . Given that the NMDA treatment induces a normal increase in co ﬁ lin activation / dephos - phorylation in IRSp53 (cid:1) / (cid:1) hippocampal neurons ( Chung et al . , 2015 ) , it appears that actin ﬁ laments in these neurons became resistant to activated co ﬁ lin . In addition , IRSp53 (cid:1) / (cid:1) SC - CA1 synapses show reduced LTD of NMDAR EPSCs ( Chung et al . , 2015 ) , a form of syn - aptic LTD distinct from the better - understood LTD of AMPAR EPSCs in aspects including the underlying mechanisms ; LTD of NMDAR EPSCs requires actin depolymerization , whereas LTD of AMPAR EPSCs requires calcineurin activation ( Morishita et al . , 2005 ; Selig et al . , 1995 ) . These results suggest the hypothesis that IRSp53 deletion leads to an abnormal stabilization of synaptic actin ﬁ la - ments , which may promote synaptic localization of NMDARs and suppress their activity - dependent removal ( Fig . 3 ) . Given that IRSp53 interacts with a large number of proteins and that IRSp53 may regulate their stability , synaptic localization , and function , IRSp53 - interacting proteins may contribute to the enhanced NMDAR function observed at IRSp53 (cid:1) / (cid:1) hippocampal synapses . In line with this possibility , mice lacking Eps8 , which directly interacts with IRSp53 ( Funato et al . , 2004 ) , show abnor - mally stable actin ﬁ laments , reduced NMDA - induced co ﬁ lin acti - vation / dephosphorylation , enhanced NMDAR function in cerebellar granule neurons , and increased ethanol resistance and consump - tion ( Offenhauser et al . , 2006 ) . In addition , mice lacking WAVE - 1 , which interacts with IRSp53 ( Miki et al . , 2000 ) and regulates dendritic spines ( Hazai et al . , 2013 ; Kim et al . , 2006 ; Soderling et al . , 2007 ) , display elevated NMDAR function and enhanced early and late LTP ( Soderling et al . , 2007 ) . Dynamin - 1 , known to interact with IRSp53 ( Chou et al . , 2014 ) , is required for NMDAR internalization induced by the dual binding of glutamate and glycine ( Nong et al . , 2003 ) . J . Kang et al . / Neuropharmacology 100 ( 2016 ) 27 e 39 33 9 . Implications of IRSp53 in psychiatric disorders Recent clinical studies have associated IRSp53 / BAIAP2 with normal human brain functions ( Luksys et al . , 2014 ) and several psychiatric disorders , including ASDs ( Celestino - Soper et al . , 2011 ; Levy et al . , 2011 ; Toma et al . , 2011 ) , schizophrenia ( Fromer et al . , 2014 ; Purcell et al . , 2014 ) , and ADHD ( Liu et al . , 2013 ; Ribases et al . , 2009 ) . A common SNP ( single - nucleotide polymorphism ) variant located in the BAIAP2 gene in healthy individuals has been associated with emotional regulation of human memory strength ( Luksys et al . , 2014 ) . In this study , modulation of verbal memory strength by negative information was associated with SNP geno - type , activity of the parahippocampal cortex , and BAIAP2 mRNAs levels . In individuals with ASDs and schizophrenia , several SNPs were associated with disease susceptibilities ( Ribases et al . , 2009 ; Toma et al . , 2011 ) . In addition , de novo copy number variations ( de - letions ) that eliminate the entire IRSp53 gene were identi ﬁ ed in in - dividuals with ASD ( Celestino - Soper et al . , 2011 ; Levy et al . , 2011 ) . De novo missense and nonsense mutations in the IRSp53 gene that lead to an F486L aa substitution in a region following the WW domain and truncation of the protein in the IMD domain , respectively , have also been identi ﬁ ed in schizophrenic patients ( Fromer et al . , 2014 ; Purcell et al . , 2014 ) . Additional details are summarized in Table 3 . 10 . Behavioral phenotypes of IRSp53 ¡ / ¡ mice Behavioral phenotypes of IRSp53 (cid:1) / (cid:1) mice have been character - ized ( Chung et al . , 2015 ; Kim et al . , 2009a ; Sawallisch et al . , 2009 ) . IRSp53 (cid:1) / (cid:1) mice show impaired social interaction , as determined by three - chamber and direct social interaction tests ( Chung et al . , 2015 ) ( Table 2 ) . In addition , ultrasonic vocalization in the pres - ence of a stranger female is reduced in male IRSp53 (cid:1) / (cid:1) mice . However , IRSp53 (cid:1) / (cid:1) mice do not show enhanced repetitive be - haviors , such as grooming and digging . IRSp53 (cid:1) / (cid:1) mice have been reported to display hyperactivity in both novel and familiar environments ( Chung et al . , 2015 ) , though another study reported largely normal locomotor activity of IRSp53 (cid:1) / (cid:1) mice in a novel environment ( Sawallisch et al . , 2009 ) . Given that the two studies use mice produced from the same ES cell line ( XG757 ; BayGenomics ) , the discrepancy might stem from their different genetic backgrounds : C57BL / 6J ( Chung et al . , 2015 ) and 129P2 / C57BL / 6 hybrid ( Sawallisch et al . , 2009 ) . In terms of cognitive function , IRSp53 (cid:1) / (cid:1) mice show impair - ments in Morris water maze spatial learning ( Kim et al . , 2009a ) , and novel object recognition memory ( Kim et al . , 2009a ) . Intriguingly , IRSp53 (cid:1) / (cid:1) mice show increased contextual fear conditioning 24 h after the training ( Sawallisch et al . , 2009 ) . These results collectively suggest that IRSp53 (cid:1) / (cid:1) mice exhibit social and cognitive de ﬁ cits and hyperactivity , which may have features in common with the symptoms of IRSp53 - associated psychiatric disorders ( e . g . , ASDs , schizophrenia , and ADHD ) . Although these behavioral phenotypes tend to support the validity of the IRSp53 (cid:1) / (cid:1) mouse model , the predictive value of this model depends on a demonstration of pharmacological reversal of the phenotypes . 11 . Reversal of abnormal phenotypes in IRSp53 ¡ / ¡ mice by NMDAR suppression Starting from the premise that abnormal behaviors of IRSp53 (cid:1) / (cid:1) mice are caused byelevated NMDAR function , a logical intervention is to attempt to normalize these behaviors by pharmacological suppression of NMDAR function . Memantine , an uncompetitive antagonist of NMDARs , is used clinically to improve cognitive functions in brain disorders , including Alzheimer ' s disease , and is Fig . 3 . A model for the proposed roles of abnormally stabilized actin ﬁ laments in anchoring of NMDARs at excitatory synapses . Under normal conditions , NMDARs are anchored at excitatory synapses through their interactions with PSD - 95 family proteins and actin ﬁ laments through a - actinins . Stimuli inducing the LTD of NMDAR EPSCs cause actin depo - lymerization through the activation / dephosphorylation of co ﬁ lin ( a negative actin regulator ) , leading to the removal of NMDARs from synapses through lateral diffusion . In the absence of IRSp53 , synaptic actin ﬁ laments are abnormally stabilized through as of yet unclear mechanisms and become resistant to activated / dephosphorylated co ﬁ lin ( dotted arrow ) , leading to enhanced synaptic retention of NMDARs under basal conditions and suppressed removal of NMDARs from synapses during LTD of NMDAR EPSCs . J . Kang et al . / Neuropharmacology 100 ( 2016 ) 27 e 39 34 known to be well tolerated likely due to its moderate af ﬁ nity and voltage - dependent channel - blocking property ( Parsons et al . , 2013 ; Thomas and Grossberg , 2009 ) . Consistent with the NMDAR hyperfunction hypothesis , acute memantine treatment ( 10 mg / kg ) 30 min before behavioral testing signi ﬁ cantly improves the social interaction of IRSp53 (cid:1) / (cid:1) mice in the three - chamber test , without affecting that of wild - type mice ( Chung et al . , 2015 ) . In addition , memantine normalizes the impaired novel object recognition in IRSp53 (cid:1) / (cid:1) mice , suggesting an effect on cognitive functions . However , memantine has no effect on the hyperactivity in these animals . Indirect suppression of NMDAR function in IRSp53 (cid:1) / (cid:1) mice by MPEP ( 2 - methyl - 6 - ( phenylethynyl ) pyridine ) , a negative allosteric modulator of metabotropic glutamate receptor 5 ( mGluR5 ) , a re - ceptor type that acts synergistically with NMDARs ( Alagarsamy et al . , 1999 ; Jia et al . , 1998 ; Kotecha and MacDonald , 2003 ; Lu et al . , 1999 ; O ' Connor et al . , 1994 ) , rescues social interaction de ﬁ - cits in IRSp53 (cid:1) / (cid:1) mice . This provides further evidence for an asso - ciation between NMDAR hyperfunction and the social de ﬁ cits in IRSp53 (cid:1) / (cid:1) mice . How could the IRSp53 (cid:1) / (cid:1) mPFC , which shows normal NMDAR function , be involved in the memantine - dependent rescue of social de ﬁ cits in these animals ? IRSp53 (cid:1) / (cid:1) neurons in the mPFC display reduced excitatory neuronal ﬁ ring with unaltered inhibitory neuronal ﬁ ring ( Chung et al . , 2015 ) . In addition , this phenotype is rescued by acute memantine treatment . This links normalization of neuronal ﬁ ring in the IRSp53 (cid:1) / (cid:1) mPFC with the memantine - dependent NMDAR suppression and rescue of social and cogni - tive de ﬁ cits in IRSp53 (cid:1) / (cid:1) mice , although further mechanistic details remain to be elucidated . 12 . Therapeutic potential of NMDAR suppression for social and cognitive de ﬁ cits associated with ASDs , schizophrenia , and ADHD Results from IRSp53 studies suggest the therapeutic potential of NMDAR suppression in alleviating social and cognitive de ﬁ cits associated with ASDs , schizophrenia , and ADHD . The therapeutic potential of memantine in the treatment of psychiatric disorders has gained credence , but remains controversial ( Canitano , 2014 ; Doyle and McDougle , 2012 ; Hosenbocus and Chahal , 2013 ; Rossignol and Frye , 2014 ; Sani et al . , 2012 ; Shim and Nadeem , 2014 ) . As such , the following issues , which are in principle test - able in model animals , need to be clari ﬁ ed . First of all , it is unclear where in the brain the abnormally enhanced NMDAR function resides and how it is associated with the observed social and cognitive impairments . In the case of IRSp53 , the protein is detected in different regions of the brain ( cortex , hippocampus , striatum , and cerebellum ) , cell types ( spiny excitatory and inhibitory neurons ) , and lateral locations within the PSD ( higher in the center vs . evenly distributed ) ( Burette et al . , 2014 ) , suggesting that IRSp53 may have distinct functions at different spatial locations . Second , the list of animals that show enhanced NMDAR function and social and cognitive de ﬁ cits that are improved by NMDAR - suppressing medications needs to be expanded . For instance , rats prenatally exposed to valproic acid ( an antiepileptic agent with teratogenic activity ) , which show ASD - like phenotypes ( social and repetitive behavior de ﬁ cits ) , display enhanced NMDAR levels and LTP in the cortex ( Rinaldi et al . , 2007 ) , indicative of enhanced NMDAR function . In addition , social defects and repetitive behav - iors in mice prenatally exposed to valproic acid are suppressed by NMDAR inhibition through acute treatment with memantine or MPEP treatment ( Kang and Kim , 2015 ; Kim et al . , 2014 ) . This new possibility d NMDAR suppression to alleviate social and cognitive de ﬁ cits in psychiatric disorders d needs to be recon - ciled with other emerging and established factors contributing to ASDs , schizophrenia , and ADHD such as excitation - inhibition bal - ance ( Bourgeron , 2009 ; Gao and Penzes , 2015 ; Rubenstein , 2010 ; Rubenstein and Merzenich , 2003 ; Yizhar et al . , 2011 ) , hyper - dopamine / hypo - glutamate ( Coyle , 2012 ; Coyle et al . , 2012 ) , and hypo - dopamine mechanisms ( Chang et al . , 2014 ; Levy , 2014 ) , respectively . Memantine acts on other types of receptors in addition to NMDARs , functioning as antagonists at serotonin ( 5 - HT 3 ) and nicotinic acetylcholine receptors , and as an agonist at dopamine ( D 2 ) receptors ( McKeage , 2009 , 2010 ) . The potential involvement of these activities in the observed rescue effects in IRSp53 (cid:1) / (cid:1) mice should be clari ﬁ ed , although the similar rescue produced by the suppression of mGluR5 , which acts synergistically with NMDARs , supports the NMDAR hyperfunction hypothesis ( Chung et al . , 2015 ) . In addition to enhanced NMDAR function , reduced NMDAR function has also been associated with ASD - like phenotypes in animal models of ASDs ( Blundell et al . , 2010 ; Lee et al . , 2015 ; Won et al . , 2012 ) . Therefore , how deviation of NMDAR function in either direction d enhancement or suppression d is associated with similar social de ﬁ cits should be clari ﬁ ed . Lastly , clinical trials of memantine for ASD treatment have yielded signi ﬁ cant improvements in 8 out of 9 studies ( Rossignol and Frye , 2014 ) ; higher - quality and larger - scale clinical studies should follow . Despite these encouraging results , memantine has been found to both improve and worsen irritability , suggesting that memantine may work for a speci ﬁ c subgroup of patients . The possible bidirectional deviation of NMDAR function in the social de ﬁ cits noted above might explain the clinical data . 13 . Conclusion This review summarized the suggested roles of IRSp53 in the regulation of synaptic actin / membranes , spine development , and synaptic function and plasticity . In addition , we described the role of NMDAR suppression in the reversal of the social and cognitive de ﬁ cits observed in IRSp53 (cid:1) / (cid:1) mice , which may help us understand IRSp53 - related and other actin / NMDAR - related psychiatric disorders . Table 3 Associations of IRSp53 with psychiatric disorders . Disorders Genetic variations Locations of mutations References ASD SNP ( rs11657991 ) Intron 2 ( Toma et al . , 2011 ) De novo CNV ( deletion ) Not applicable ( Celestino - Soper et al . , 2011 ) De novo CNV ( deletion ) Not applicable ( Levy et al . , 2011 ) Schizophrenia Missense ( F486L ) Exon 12 ( After WW domain ) ( Fromer et al . , 2014 ) Codon deletion ( CCCT / C ) 3 0 - UTR ( chr17 : 79089626 e 79089629 ) Nonsense ( G / T ) Exon 2 ( IMD domain ; chr17 : 79027528 ) ( Purcell et al . , 2014 ) ADHD SNP ( rs8079626 , rs11657991 , rs7503597 , rs7210438 ) Introns 1 , 2 , 3 , 5 ( Ribases et al . , 2009 ) SNP ( rs4969239 , rs3934492 , rs4969385 ) Introns 1 , 3 , 6 ( Liu et al . , 2013 ) J . Kang et al . / Neuropharmacology 100 ( 2016 ) 27 e 39 35 Acknowledgments This work was supported by the Institute for Basic Science ( IBS ) ( IBS - R002 - D1 to E . K . ) . References Abbott , M . A . , Wells , D . G . , Fallon , J . R . , 1999 . The insulin receptor tyrosine kinase substrate p58 / 53 and the insulin receptor are components of CNS synapses . J . Neurosci . 19 , 7300 e 7308 . Ahmed , S . , Goh , W . I . , Bu , W . , 2010 . I - BAR domains , IRSp53 and ﬁ lopodium forma - tion . Semin . Cell Dev . Biol . 21 , 350 e 356 . Alagarsamy , S . , Marino , M . J . , Rouse , S . T . , Gereau , R . W . T . , Heinemann , S . F . , Conn , P . J . , 1999 . Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems . Nat . Neurosci . 2 , 234 e 240 . Allison , D . W . , Gelfand , V . I . , Spector , I . , Craig , A . M . , 1998 . Role of actin in anchoring postsynaptic receptors in cultured hippocampal neurons : differential attach - ment of NMDA versus AMPA receptors . J . Neurosci . 18 , 2423 e 2436 . Alpi , E . , Landi , E . , Barilari , M . , Serresi , M . , Salvadori , P . , Bachi , A . , Dente , L . , 2009 . Channel - interacting PDZ protein , ‘ CIPP ’ , interacts with proteins involved in cytoskeletal dynamics . Biochem . J . 419 , 289 e 300 . Alvarez , C . E . , Sutcliffe , J . G . , Thomas , E . A . , 2002 . Novel isoform of insulin receptor substrate p53 / p58 is generated by alternative splicing in the CRIB / SH3 - binding region . J . Biol . Chem . 277 , 24728 e 24734 . Alvarez , N . , Williams , R . , 1998 . Comment on Vadney and Kraushaar ' s Effect of switching from Depakene to generic valproic acid on individuals with mental retardation . Ment . Retard . 36 , 330 e 331 . Bachmann - Gagescu , R . , Mefford , H . C . , Cowan , C . , Glew , G . M . , Hing , A . V . , Wallace , S . , Bader , P . I . , Hamati , A . , Reitnauer , P . J . , Smith , R . , Stockton , D . W . , Muhle , H . , Helbig , I . , Eichler , E . E . , Ballif , B . C . , Rosenfeld , J . , Tsuchiya , K . D . , 2010 . Recurrent 200 - kb deletions of 16p11 . 2 that include the SH2B1 gene are associated with developmental delay and obesity . Genet . Med . 12 , 641 e 647 . Balan , S . , Yamada , K . , Hattori , E . , Iwayama , Y . , Toyota , T . , Ohnishi , T . , Maekawa , M . , Toyoshima , M . , Iwata , Y . , Suzuki , K . , Kikuchi , M . , Yoshikawa , T . , 2013 . Population - speci ﬁ c haplotype association of the postsynaptic density gene DLG4 with schizophrenia , in family - based association studies . PLoS One 8 , e70302 . Bard , L . , Groc , L . , 2011 . Glutamate receptor dynamics and protein interaction : les - sons from the NMDA receptor . Mol . Cell . Neurosci . 48 , 298 e 307 . Barilari , M . , Dente , L . , 2010 . The neuronal proteins CIPP , cypin and IRSp53 form a tripartite complex mediated by PDZ and SH3 domains . Biol . Chem . 391 , 1169 e 1174 . Bausen , M . , Fuhrmann , J . C . , Betz , H . , O ' Sullivan , G . , A . , 2006 . The state of the actin cytoskeleton determines its association with gephyrin : role of ena / VASP family members . Mol . Cell . Neurosci . 31 , 376 e 386 . Blundell , J . , Blaiss , C . A . , Etherton , M . R . , Espinosa , F . , Tabuchi , K . , Walz , C . , Bolliger , M . F . , Sudhof , T . C . , Powell , C . M . , 2010 . Neuroligin - 1 deletion results in impaired spatial memory and increased repetitive behavior . J . Neurosci . 30 , 2115 e 2129 . Bockmann , J . , Kreutz , M . R . , Gundel ﬁ nger , E . D . , Bockers , T . M . , 2002 . ProSAP / Shank postsynaptic density proteins interact with insulin receptor tyrosine kinase substrate IRSp53 . J . Neurochem . 83 , 1013 e 1017 . Bosch , M . , Hayashi , Y . , 2012 . Structural plasticity of dendritic spines . Curr . Opin . Neurobiol . 22 , 383 e 388 . Bourgeron , T . , 2009 . A synaptic trek to autism . Curr . Opin . Neurobiol . 19 , 231 e 234 . Burette , A . C . , Park , H . , Weinberg , R . J . , 2014 . Postsynaptic distribution of IRSp53 in spiny excitatory and inhibitory neurons . J . Comp . Neurol . 522 , 2164 e 2178 . Calabrese , B . , Wilson , M . S . , Halpain , S . , 2006 . Development and regulation of den - dritic spine synapses . Physiol . Bethesda 21 , 38 e 47 . Canitano , R . , 2014 . New experimental treatments for core social domain in autism spectrum disorders . Front . Pediatr . 2 , 61 . Celestino - Soper , P . B . , Shaw , C . A . , Sanders , S . J . , Li , J . , Murtha , M . T . , Ercan - Sencicek , A . G . , Davis , L . , Thomson , S . , Gambin , T . , Chinault , A . C . , Ou , Z . , German , J . R . , Milosavljevic , A . , Sutcliffe , J . S . , Cook Jr . , E . H . , Stankiewicz , P . , State , M . W . , Beaudet , A . L . , 2011 . Use of array CGH to detect exonic copy number variants throughout the genome in autism families detects a novel deletion in TMLHE . Hum . Mol . Genet . 20 , 4360 e 4370 . Chang , J . P . , Lane , H . Y . , Tsai , G . E . , 2014 . Attention de ﬁ cit hyperactivity disorderand N - methyl - D - aspartate ( NMDA ) dysregulation . Curr . Pharm . Des . 20 ( 32 ) , 5180 e 5185 . Chazeau , A . , Mehidi , A . , Nair , D . , Gautier , J . J . , Leduc , C . , Chamma , I . , Kage , F . , Kechkar , A . , Thoumine , O . , Rottner , K . , Choquet , D . , Gautreau , A . , Sibarita , J . B . , Giannone , G . , 2014 . Nanoscale segregation of actin nucleation and elongation factors determines dendritic spine protrusion . EMBO J . 33 , 2745 e 2764 . Chen , B . S . , Roche , K . W . , 2007 . Regulation of NMDA receptors by phosphorylation . Neuropharmacology 53 , 362 e 368 . Chen , C . J . , Shih , C . H . , Chang , Y . J . , Hong , S . J . , Li , T . N . , Wang , L . H . , Chen , L . , 2015 . SH2B1 and IRSp53 proteins promote the formation of dendrites and dendritic branches . J . Biol . Chem . 290 , 6010 e 6021 . Cheng , D . , Hoogenraad , C . C . , Rush , J . , Ramm , E . , Schlager , M . A . , Duong , D . M . , Xu , P . , Wijayawardana , S . R . , Hanfelt , J . , Nakagawa , T . , Sheng , M . , Peng , J . , 2006 . Relative and absolute quanti ﬁ cation of postsynaptic density proteome isolated from rat forebrain and cerebellum . Mol . Cell . Proteom . 5 , 1158 e 1170 . Cho , I . H . , Kim , D . H . , Lee , M . J . , Bae , J . , Lee , K . H . , Song , W . K . , 2013 . SPIN90 phosphorylation modulates spine structure and synaptic function . PLoS One 8 , e54276 . Choi , J . , Ko , J . , Racz , B . , Burette , A . , Lee , J . R . , Kim , S . , Na , M . , Lee , H . W . , Kim , K . , Weinberg , R . J . , Kim , E . , 2005 . Regulation of dendritic spine morphogenesis by insulin receptor substrate 53 , a downstream effector of Rac1 and Cdc42 small GTPases . J . Neurosci . 25 , 869 e 879 . Chou , A . M . , Sem , K . P . , Wright , G . D . , Sudhaharan , T . , Ahmed , S . , 2014 . Dynamin1 is a novel target for IRSp53 protein and works with mammalian enabled ( Mena ) protein and Eps8 to regulate ﬁ lopodial dynamics . J . Biol . Chem . 289 , 24383 e 24396 . Chung , W . , Choi , S . Y . , Lee , E . , Park , H . , Kang , J . , Park , H . , Choi , Y . , Lee , D . , Park , S . G . , Kim , R . , Cho , Y . S . , Choi , J . , Kim , M . H . , Lee , J . W . , Lee , S . , Rhim , I . , Jung , M . W . , Kim , D . , Bae , Y . C . , Kim , E . , 2015 . Social de ﬁ cits in IRSp53 mutant mice improved by NMDAR and mGluR5 suppression . Nat . Neurosci . 18 , 435 e 443 . Cingolani , L . A . , Goda , Y . , 2008 . Actin in action : the interplay between the actin cytoskeleton and synaptic ef ﬁ cacy . Nat . Rev . Neurosci . 9 , 344 e 356 . Connolly , B . A . , Rice , J . , Feig , L . A . , Buchsbaum , R . J . , 2005 . Tiam1 - IRSp53 complex formation directs speci ﬁ city of rac - mediated actin cytoskeleton regulation . Mol . Cell . Biol . 25 , 4602 e 4614 . Coyle , J . T . , 2012 . NMDA receptor and schizophrenia : a brief history . Schizophr . Bull . 38 , 920 e 926 . Coyle , J . T . , Basu , A . , Benneyworth , M . , Balu , D . , Konopaske , G . , 2012 . Glutamatergic synaptic dysregulation in schizophrenia : therapeutic implications . Handb . Exp . Pharmacol . 267 e 295 . Di Paolo , G . , De Camilli , P . , 2006 . Phosphoinositides in cell regulation and mem - brane dynamics . Nature 443 , 651 e 657 . Disanza , A . , Bisi , S . , Winterhoff , M . , Milanesi , F . , Ushakov , D . S . , Kast , D . , Marighetti , P . , Romet - Lemonne , G . , Muller , H . M . , Nickel , W . , Linkner , J . , Waterschoot , D . , Ampe , C . , Cortellino , S . , Palamidessi , A . , Dominguez , R . , Carlier , M . F . , Faix , J . , Scita , G . , 2013 . CDC42 switches IRSp53 from inhibition of actin growth to elongation by clustering of VASP . EMBO J . 32 , 2735 e 2750 . Disanza , A . , Mantoani , S . , Hertzog , M . , Gerboth , S . , Frittoli , E . , Steffen , A . , Berhoerster , K . , Kreienkamp , H . J . , Milanesi , F . , Di Fiore , P . P . , Ciliberto , A . , Stradal , T . E . , Scita , G . , 2006 . Regulation of cell shape by Cdc42 is mediated by the synergic actin - bundling activity of the Eps8 - IRSp53 complex . Nat . Cell Biol . 8 , 1337 e 1347 . Doyle , C . A . , McDougle , C . J . , 2012 . Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan . Di - alogues Clin . Neurosci . 14 , 263 e 279 . Drees , F . , Gertler , F . B . , 2008 . Ena / VASP : proteins at the tip of the nervous system . Curr . Opin . Neurobiol . 18 , 53 e 59 . Egger , G . , Roetzer , K . M . , Noor , A . , Lionel , A . C . , Mahmood , H . , Schwarzbraun , T . , Boright , O . , Mikhailov , A . , Marshall , C . R . , Windpassinger , C . , Petek , E . , Scherer , S . W . , Kaschnitz , W . , Vincent , J . B . , 2014 . Identi ﬁ cation of risk genes for autism spectrum disorder through copy number variation analysis in Austrian families . Neurogenetics 15 , 117 e 127 . Emes , R . D . , Grant , S . G . , 2012 . Evolution of synapse complexity and diversity . Annu . Rev . Neurosci . 35 , 111 e 131 . Fan , X . , Jin , W . Y . , Wang , Y . T . , 2014 . The NMDA receptor complex : a multifunctional machine at the glutamatergic synapse . Front . Cell . Neurosci . 8 , 160 . Ferguson , S . M . , De Camilli , P . , 2012 . Dynamin , a membrane - remodelling GTPase . Nat . Rev . Mol . Cell Biol . 13 , 75 e 88 . Feyder , M . , Karlsson , R . M . , Mathur , P . , Lyman , M . , Bock , R . , Momenan , R . , Munasinghe , J . , Scattoni , M . L . , Ihne , J . , Camp , M . , Graybeal , C . , Strathdee , D . , Begg , A . , Alvarez , V . A . , Kirsch , P . , Rietschel , M . , Cichon , S . , Walter , H . , Meyer - Lindenberg , A . , Grant , S . G . , Holmes , A . , 2010 . Association of mouse Dlg4 ( PSD - 95 ) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams ' syndrome . Am . J . Psychiatry 167 , 1508 e 1517 . Foote , M . , Zhou , Y . , 2012 . 14 - 3 - 3 proteins in neurological disorders . Int . J . Biochem . Mol . Biol . 3 , 152 e 164 . Fromer , M . , Pocklington , A . J . , Kavanagh , D . H . , Williams , H . J . , Dwyer , S . , Gormley , P . , Georgieva , L . , Rees , E . , Palta , P . , Ruderfer , D . M . , Carrera , N . , Humphreys , I . , Johnson , J . S . , Roussos , P . , Barker , D . D . , Banks , E . , Milanova , V . , Grant , S . G . , Hannon , E . , Rose , S . A . , Chambert , K . , Mahajan , M . , Scolnick , E . M . , Moran , J . L . , Kirov , G . , Palotie , A . , McCarroll , S . A . , Holmans , P . , Sklar , P . , Owen , M . J . , Purcell , S . M . , O ' Donovan , M . C . , 2014 . De novo mutations in schizophrenia implicate synaptic networks . Nature 506 , 179 e 184 . Fujiwara , T . , Mammoto , A . , Kim , Y . , Takai , Y . , 2000 . Rho small G - protein - dependent binding of mDia to an Src homology 3 domain - containing IRSp53 / BAIAP2 . Biochem . Biophys . Res . Commun . 271 , 626 e 629 . Funato , Y . , Terabayashi , T . , Suenaga , N . , Seiki , M . , Takenawa , T . , Miki , H . , 2004 . IRSp53 / Eps8 complex is important for positive regulation of Rac and cancer cell motility / invasiveness . Cancer Res . 64 , 5237 e 5244 . Furukawa , K . , Fu , W . , Li , Y . , Witke , W . , Kwiatkowski , D . J . , Mattson , M . P . , 1997 . The actin - severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons . J . Neurosci . 17 , 8178 e 8186 . Gao , R . , Penzes , P . , 2015 . Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders . Curr . Mol . Med . 15 ( 20 ) , 146 e 167 . Giesemann , T . , Schwarz , G . , Nawrotzki , R . , Berhorster , K . , Rothkegel , M . , Schluter , K . , Schrader , N . , Schindelin , H . , Mendel , R . R . , Kirsch , J . , Jockusch , B . M . , 2003 . Complex formation between the postsynaptic scaffolding protein gephyrin , pro ﬁ lin , and mena : a possible link to the micro ﬁ lament system . J . Neurosci . 23 , J . Kang et al . / Neuropharmacology 100 ( 2016 ) 27 e 39 36 8330 e 8339 . Goh , W . I . , Lim , K . B . , Sudhaharan , T . , Sem , K . P . , Bu , W . , Chou , A . M . , Ahmed , S . , 2012 . mDia1 and WAVE2 proteins interact directly with IRSp53 in ﬁ lopodia and are involved in ﬁ lopodium formation . J . Biol . Chem . 287 , 4702 e 4714 . Govek , E . E . , Newey , S . E . , Van Aelst , L . , 2005 . The role of the Rho GTPases in neuronal development . Genes Dev . 19 , 1 e 49 . Govind , S . , Kozma , R . , Monfries , C . , Lim , L . , Ahmed , S . , 2001 . Cdc42Hs facilitates cytoskeletal reorganization and neurite outgrowth by localizing the 58 - kD in - sulin receptor substrate to ﬁ lamentous actin . J . Cell Biol . 152 , 579 e 594 . Guilmatre , A . , Huguet , G . , Delorme , R . , Bourgeron , T . , 2014 . The emerging role of SHANK genes in neuropsychiatric disorders . Dev . Neurobiol . 74 , 113 e 122 . Han , K . , Holder Jr . , J . L . , Schaaf , C . P . , Lu , H . , Chen , H . , Kang , H . , Tang , J . , Wu , Z . , Hao , S . , Cheung , S . W . , Yu , P . , Sun , H . , Breman , A . M . , Patel , A . , Lu , H . C . , Zoghbi , H . Y . , 2013 . SHANK3 overexpression causes manic - like behaviour with unique pharmaco - genetic properties . Nature 503 , 72 e 77 . Harris , K . M . , Weinberg , R . J . , 2012 . Ultrastructure of synapses in the mammalian brain . Cold Spring Harb . Perspect . Biol . 4 . Hazai , D . , Szudoczki , R . , Ding , J . , Soderling , S . H . , Weinberg , R . J . , Sotonyi , P . , Racz , B . , 2013 . Ultrastructural abnormalities in CA1 hippocampus caused by deletion of the actin regulator WAVE - 1 . PLoS One 8 , e75248 . Hong , S . J . , Liu , S . T . , Chen , C . J . , Chen , L . , 2014 . SH2B1 increases the numbers of IRSp53 - induced ﬁ lopodia . Biochim . Biophys . Acta 1840 , 3335 e 3344 . Horak , M . , Petralia , R . S . , Kaniakova , M . , Sans , N . , 2014 . ER to synapse traf ﬁ cking of NMDA receptors . Front . Cell . Neurosci . 8 , 394 . Hori , K . , Konno , D . , Maruoka , H . , Sobue , K . , 2003 . MALS is a binding partner of IRSp53 at cell e cell contacts . FEBS Lett . 554 , 30 e 34 . Hori , K . , Yasuda , H . , Konno , D . , Maruoka , H . , Tsumoto , T . , Sobue , K . , 2005 . NMDA receptor - dependent synaptic translocation of insulin receptor substrate p53 via protein kinase C signaling . J . Neurosci . 25 , 2670 e 2681 . Hosenbocus , S . , Chahal , R . , 2013 . Memantine : a review of possible uses in child and adolescent psychiatry . J . Can . Acad . Child Adolesc . Psychiatry 22 , 166 e 171 . Hotulainen , P . , Hoogenraad , C . C . , 2010 . Actin in dendritic spines : connecting dy - namics to function . J . Cell Biol . 189 , 619 e 629 . Husi , H . , Grant , S . G . , 2001 . Isolation of 2000 - kDa complexes of N - methyl - D - aspar - tate receptor and postsynaptic density 95 from mouse brain . J . Neurochem . 77 , 281 e 291 . Husi , H . , Ward , M . A . , Choudhary , J . S . , Blackstock , W . P . , Grant , S . G . , 2000 . Proteomic analysis of NMDA receptor - adhesion protein signaling complexes . Nat . Neuro - sci . 3 , 661 e 669 . Irie , F . , Yamaguchi , Y . , 2004 . EPHB receptor signaling in dendritic spine develop - ment . Front . Biosci . 9 , 1365 e 1373 . Ito , H . , Morishita , R . , Shinoda , T . , Iwamoto , I . , Sudo , K . , Okamoto , K . , Nagata , K . , 2010 . Dysbindin - 1 , WAVE2 and Abi - 1 form a complex that regulates dendritic spine formation . Mol . Psychiatry 15 , 976 e 986 . Jia , Z . , Lu , Y . , Henderson , J . , Taverna , F . , Romano , C . , Abramow - Newerly , W . , Wojtowicz , J . M . , Roder , J . , 1998 . Selective abolition of the NMDA component of long - term potentiation in mice lacking mGluR5 . Learn . Mem . 5 , 331 e 343 . Kakinuma , N . , Roy , B . C . , Zhu , Y . , Wang , Y . , Kiyama , R . , 2008 . Kank regulates RhoA - dependent formation of actin stress ﬁ bers and cell migration via 14 - 3 - 3 in PI3K - Akt signaling . J . Cell Biol . 181 , 537 e 549 . Kang , J . , Kim , E . , 2015 . Suppression of NMDA receptor function in mice prenatally exposed tovalproic acid improves social de ﬁ cits and repetitive behaviors . Front . Cell . Neurosci . 8 , 17 . Kast , D . J . , Yang , C . , Disanza , A . , Boczkowska , M . , Madasu , Y . , Scita , G . , Svitkina , T . , Dominguez , R . , 2014 . Mechanism of IRSp53 inhibition and combinatorial acti - vation by Cdc42 and downstream effectors . Nat . Struct . Mol . Biol . 21 , 413 e 422 . Kennedy , M . B . , 1993 . The postsynaptic density . Curr . Opin . Neurobiol . 3 , 732 e 737 . Kenny , E . M . , Cormican , P . , Furlong , S . , Heron , E . , Kenny , G . , Fahey , C . , Kelleher , E . , Ennis , S . , Tropea , D . , Anney , R . , Corvin , A . P . , Donohoe , G . , Gallagher , L . , Gill , M . , Morris , D . W . , 2014 . Excess of rare novel loss - of - function variants in synaptic genes in schizophrenia and autism spectrum disorders . Mol . Psychiatry 19 , 872 e 879 . Kim , I . H . , Racz , B . , Wang , H . , Burianek , L . , Weinberg , R . , Yasuda , R . , Wetsel , W . C . , Soderling , S . H . , 2013 . Disruption of Arp2 / 3 results in asymmetric structural plasticity of dendritic spines and progressive synaptic and behavioral abnor - malities . J . Neurosci . 33 , 6081 e 6092 . Kim , I . H . , Rossi , M . A . , Aryal , D . K . , Racz , B . , Kim , N . , Uezu , A . , Wang , F . , Wetsel , W . C . , Weinberg , R . J . , Yin , H . , Soderling , S . H . , 2015 . Spine pruning drives antipsychotic - sensitive locomotion via circuit control of striatal dopamine . Nat . Neurosci . 18 , 883 e 891 . Kim , K . C . , Lee , D . K . , Go , H . S . , Kim , P . , Choi , C . S . , Kim , J . W . , Jeon , S . J . , Song , M . R . , Shin , C . Y . , 2014 . Pax6 - dependent cortical glutamatergic neuronal differentiation regulates autism - like behavior in prenatally valproic acid - exposed rat offspring . Mol . Neurobiol . 49 , 512 e 528 . Kim , M . H . , Choi , J . , Yang , J . , Chung , W . , Kim , J . H . , Paik , S . K . , Kim , K . , Han , S . , Won , H . , Bae , Y . S . , Cho , S . H . , Seo , J . , Bae , Y . C . , Choi , S . Y . , Kim , E . , 2009a . Enhanced NMDA receptor - mediated synaptic transmission , enhanced long - term potentiation , and impaired learning and memory in mice lacking IRSp53 . J . Neurosci . 29 , 1586 e 1595 . Kim , S . M . , Choi , K . Y . , Cho , I . H . , Rhy , J . H . , Kim , S . H . , Park , C . S . , Kim , E . , Song , W . K . , 2009b . Regulation of dendritic spine morphology by SPIN90 , a novel Shank binding partner . J . Neurochem . 109 , 1106 e 1117 . Kim , Y . , Sung , J . Y . , Ceglia , I . , Lee , K . W . , Ahn , J . H . , Halford , J . M . , Kim , A . M . , Kwak , S . P . , Park , J . B . , Ho Ryu , S . , Schenck , A . , Bardoni , B . , Scott , J . D . , Nairn , A . C . , Greengard , P . , 2006 . Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology . Nature 442 , 814 e 817 . Korkotian , E . , Frotscher , M . , Segal , M . , 2014 . Synaptopodin regulates spine plasticity : mediation by calcium stores . J . Neurosci . 34 , 11641 e 11651 . Korobova , F . , Svitkina , T . , 2010 . Molecular architecture of synaptic actin cytoskeleton in hippocampal neurons reveals a mechanism of dendritic spine morphogen - esis . Mol . Biol . Cell 21 , 165 e 176 . Kotecha , S . A . , MacDonald , J . F . , 2003 . Signaling molecules and receptor transduction cascades that regulate NMDA receptor - mediatedsynaptic transmission . Int . Rev . Neurobiol . 54 , 51 e 106 . Krugmann , S . , Jordens , I . , Gevaert , K . , Driessens , M . , Vandekerckhove , J . , Hall , A . , 2001 . Cdc42 induces ﬁ lopodia by promoting the formation of an IRSp53 : Mena complex . Curr . Biol . 11 , 1645 e 1655 . Kurschner , C . , Mermelstein , P . G . , Holden , W . T . , Surmeier , D . J . , 1998 . CIPP , a novel multivalent PDZ domain protein , selectively interacts with kir4 . 0 family members , NMDA receptor subunits , neurexins , and neuroligins . Mol . Cell . Neurosci . 11 , 161 e 172 . Lau , C . G . , Zukin , R . S . , 2007 . NMDA receptor traf ﬁ cking in synaptic plasticity and neuropsychiatric disorders . Nat . Rev . Neurosci . 8 , 413 e 426 . Leblond , C . S . , Nava , C . , Polge , A . , Gauthier , J . , Huguet , G . , Lumbroso , S . , Giuliano , F . , Stordeur , C . , Depienne , C . , Mouzat , K . , Pinto , D . , Howe , J . , Lemiere , N . , Durand , C . M . , Guibert , J . , Ey , E . , Toro , R . , Peyre , H . , Mathieu , A . , Amsellem , F . , Rastam , M . , Gillberg , I . C . , Rappold , G . A . , Holt , R . , Monaco , A . P . , Maestrini , E . , Galan , P . , Heron , D . , Jacquette , A . , Afenjar , A . , Rastetter , A . , Brice , A . , Devillard , F . , Assouline , B . , Laffargue , F . , Lespinasse , J . , Chiesa , J . , Rivier , F . , Bonneau , D . , Regnault , B . , Zelenika , D . , Delepine , M . , Lathrop , M . , Sanlaville , D . , Schluth - Bolard , C . , Edery , P . , Perrin , L . , Tabet , A . C . , Schmeisser , M . J . , Boeckers , T . M . , Coleman , M . , Sato , D . , Szatmari , P . , Scherer , S . W . , Rouleau , G . A . , Betancur , C . , Leboyer , M . , Gillberg , C . , Delorme , R . , Bourgeron , T . , 2014 . Meta - analysis of SHANK mutations in autism spectrum disorders : a gradient of severity in cognitive impairments . PLoS Genet . 10 , e1004580 . Lee , E . J . , Choi , S . Y . , Kim , E . , 2015 . NMDA receptor dysfunction in autism spectrum disorders . Curr . Opin . Pharmacol . 20C , 8 e 13 . Lee , S . , Lee , K . , Hwang , S . , Kim , S . H . , Song , W . K . , Park , Z . Y . , Chang , S . , 2006 . SPIN90 / WISH interacts with PSD - 95 and regulates dendritic spinogenesis via an N - WASP - independent mechanism . EMBO J . 25 , 4983 e 4995 . Lennertz , L . , Wagner , M . , Wolwer , W . , Schuhmacher , A . , Frommann , I . , Berning , J . , Schulze - Rauschenbach , S . , Landsberg , M . W . , Steinbrecher , A . , Alexander , M . , Franke , P . E . , Pukrop , R . , Ruhrmann , S . , Bechdolf , A . , Gaebel , W . , Klosterkotter , J . , Hafner , H . , Maier , W . , Mossner , R . , 2012 . A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinicallyat risk for psychosis . Eur . Arch . Psychiatry Clin . Neurosci . 262 , 117 e 124 . Lerer , I . , Sagi , M . , Meiner , V . , Cohen , T . , Zlotogora , J . , Abeliovich , D . , 2005 . Deletion of the ANKRD15 gene at 9p24 . 3 causes parent - of - origin - dependent inheritance of familial cerebral palsy . Hum . Mol . Genet . 14 , 3911 e 3920 . Levy , D . , Ronemus , M . , Yamrom , B . , Lee , Y . H . , Leotta , A . , Kendall , J . , Marks , S . , Lakshmi , B . , Pai , D . , Ye , K . , Buja , A . , Krieger , A . , Yoon , S . , Troge , J . , Rodgers , L . , Iossifov , I . , Wigler , M . , 2011 . Rare de novo and transmitted copy - number vari - ation in autistic spectrum disorders . Neuron 70 , 886 e 897 . Levy , F . , 2014 . Applications of pharmacogenetics in children with attention - de ﬁ cit / hyperactivity disorder . Pharmgenomics Pers . Med . 7 , 349 e 356 . Lim , K . B . , Bu , W . , Goh , W . I . , Koh , E . , Ong , S . H . , Pawson , T . , Sudhaharan , T . , Ahmed , S . , 2008 . The Cdc42 effector IRSp53 generates ﬁ lopodia by coupling membrane protrusion with actin dynamics . J . Biol . Chem . 283 , 20454 e 20472 . Liu , L . , Sun , L . , Li , Z . H . , Li , H . M . , Wei , L . P . , Wang , Y . F . , Qian , Q . J . , 2013 . BAIAP2 exhibits association to childhood ADHD especially predominantly inattentive subtype in Chinese Han subjects . Behav . Brain Funct . 9 , 48 . Lu , W . Y . , Xiong , Z . G . , Lei , S . , Orser , B . A . , Dudek , E . , Browning , M . D . , MacDonald , J . F . , 1999 . G - protein - coupled receptors act via protein kinase C and Src to regulate NMDA receptors . Nat . Neurosci . 2 , 331 e 338 . Luksys , G . , Ackermann , S . , Coynel , D . , Fastenrath , M . , Gschwind , L . , Heck , A . , Rasch , B . , Spalek , K . , Vogler , C . , Papassotiropoulos , A . , de Quervain , D . , 2014 . BAIAP2 is related to emotional modulation of human memory strength . PLoS One 9 , e83707 . Mattila , P . K . , Pykalainen , A . , Saarikangas , J . , Paavilainen , V . O . , Vihinen , H . , Jokitalo , E . , Lappalainen , P . , 2007 . Missing - in - metastasis and IRSp53 deform PI ( 4 , 5 ) P2 - rich membranes by an inverse BAR domain - like mechanism . J . Cell Biol . 176 , 953 e 964 . McKeage , K . , 2009 . Memantine : a review of its use in moderate to severe Alz - heimer ' s disease . CNS Drugs 23 , 881 e 897 . McKeage , K . , 2010 . Spotlight on memantine in moderate to severe Alzheimer ' s disease . Drugs Aging 27 , 177 e 179 . Menna , E . , Zambetti , S . , Morini , R . , Donzelli , A . , Disanza , A . , Calvigioni , D . , Braida , D . , Nicolini , C . , Orlando , M . , Fossati , G . , Cristina Regondi , M . , Pattini , L . , Frassoni , C . , Francolini , M . , Scita , G . , Sala , M . , Fahnestock , M . , Matteoli , M . , 2013 . Eps8 con - trols dendritic spine density and synaptic plasticity through its actin - capping activity . EMBO J . 32 , 1730 e 1744 . Miki , H . , Suetsugu , S . , Takenawa , T . , 1998 . WAVE , a novel WASP - family protein involved in actin reorganization induced by Rac . EMBO J . 17 , 6932 e 6941 . Miki , H . , Takenawa , T . , 2002 . WAVE2 serves a functional partner of IRSp53 by regulating its interaction with Rac . Biochem . Biophys . Res . Commun . 293 , 93 e 99 . Miki , H . , Yamaguchi , H . , Suetsugu , S . , Takenawa , T . , 2000 . IRSp53 is an essential intermediate between Rac and WAVE in the regulation of membrane ruf ﬂ ing . Nature 408 , 732 e 735 . Millard , T . H . , Bompard , G . , Heung , M . Y . , Dafforn , T . R . , Scott , D . J . , Machesky , L . M . , J . Kang et al . / Neuropharmacology 100 ( 2016 ) 27 e 39 37 Futterer , K . , 2005 . Structural basis of ﬁ lopodia formation induced by the IRSp53 / MIM homology domain of human IRSp53 . EMBO J . 24 , 240 e 250 . Millard , T . H . , Dawson , J . , Machesky , L . M . , 2007 . Characterisation of IRTKS , a novel IRSp53 / MIM family actin regulator with distinct ﬁ lament bundling properties . J . Cell Sci . 120 , 1663 e 1672 . Miyahara , A . , Okamura - Oho , Y . , Miyashita , T . , Hoshika , A . , Yamada , M . , 2003 . Genomic structure and alternative splicing of the insulin receptor tyrosine ki - nase substrate of 53 - kDa protein . J . Hum . Genet . 48 , 410 e 414 . Mizuno , M . , Matsumoto , A . , Hamada , N . , Ito , H . , Miyauchi , A . , Jimbo , E . F . , Momoi , M . Y . , Tabata , H . , Yamagata , T . , Nagata , K . , 2015 . Role of an adaptor protein Lin - 7B in brain development : possible involvement in autism spectrum disorders . J . Neurochem . 132 , 61 e 69 . Morishita , W . , Marie , H . , Malenka , R . C . , 2005 . Distinct triggering and expression mechanisms underlie LTD of AMPA and NMDA synaptic responses . Nat . Neu - rosci . 8 , 1043 e 1050 . Myers , K . R . , Wang , G . , Sheng , Y . , Conger , K . K . , Casanova , J . E . , Zhu , J . J . , 2012 . Arf6 - GEF BRAG1 regulates JNK - mediated synaptic removal of GluA1 - containing AMPA receptors : a new mechanism for nonsyndromic X - linked mental disorder . J . Neurosci . 32 , 11716 e 11726 . Naz , S . , Grif ﬁ th , A . J . , Riazuddin , S . , Hampton , L . L . , Battey Jr . , J . F . , Khan , S . N . , Riazuddin , S . , Wilcox , E . R . , Friedman , T . B . , 2004 . Mutations of ESPN cause autosomal recessive deafness and vestibular dysfunction . J . Med . Genet . 41 , 591 e 595 . Neukirchen , D . , Bradke , F . , 2011 . Neuronal polarization and the cytoskeleton . Semin . Cell Dev . Biol . 22 , 825 e 833 . Newpher , T . M . , Ehlers , M . D . , 2008 . Glutamate receptor dynamics in dendritic microdomains . Neuron 58 , 472 e 497 . Nong , Y . , Huang , Y . Q . , Ju , W . , Kalia , L . V . , Ahmadian , G . , Wang , Y . T . , Salter , M . W . , 2003 . Glycine binding primes NMDA receptor internalization . Nature 422 , 302 e 307 . O ' Connor , J . J . , Rowan , M . J . , Anwyl , R . , 1994 . Long - lasting enhancement of NMDA receptor - mediated synaptic transmission by metabotropic glutamate receptor activation . Nature 367 , 557 e 559 . Oda , K . , Shiratsuchi , T . , Nishimori , H . , Inazawa , J . , Yoshikawa , H . , Taketani , Y . , Nakamura , Y . , Tokino , T . , 1999 . Identi ﬁ cation of BAIAP2 ( BAI - associated protein 2 ) , a novel human homologue of hamster IRSp53 , whose SH3 domain interacts with the cytoplasmic domain of BAI1 . Cytogenet . Cell Genet . 84 , 75 e 82 . Oertner , T . G . , Matus , A . , 2005 . Calcium regulation of actin dynamics in dendritic spines . Cell Calcium 37 , 477 e 482 . Offenhauser , N . , Castelletti , D . , Mapelli , L . , Soppo , B . E . , Regondi , M . C . , Rossi , P . , D ' Angelo , E . , Frassoni , C . , Amadeo , A . , Tocchetti , A . , Pozzi , B . , Disanza , A . , Guarnieri , D . , Betsholtz , C . , Scita , G . , Heberlein , U . , Di Fiore , P . P . , 2006 . Increased ethanol resistance and consumption in Eps8 knockout mice correlates with altered actin dynamics . Cell 127 , 213 e 226 . Okamura - Oho , Y . , Miyashita , T . , Ohmi , K . , Yamada , M . , 1999 . Dentatorubral - pallid - oluysian atrophy protein interacts through a proline - rich region near poly - glutamine with the SH3 domain of an insulin receptor tyrosine kinase substrate . Hum . Mol . Genet . 8 , 947 e 957 . Okamura - Oho , Y . , Miyashita , T . , Yamada , M . , 2001 . Distinctive tissue distribution and phosphorylation of IRSp53 isoforms . Biochem . Biophys . Res . Commun . 289 , 957 e 960 . Paoletti , P . , Bellone , C . , Zhou , Q . , 2013 . NMDA receptor subunit diversity : impact on receptor properties , synaptic plasticity and disease . Nat . Rev . Neurosci . 14 , 383 e 400 . Parsons , C . G . , Danysz , W . , Dekundy , A . , Pulte , I . , 2013 . Memantine and cholinesterase inhibitors : complementary mechanisms in the treatment of Alzheimer ' s dis - ease . Neurotox . Res . 24 , 358 e 369 . Penzes , P . , Cahill , M . E . , 2012 . Deconstructing signal transduction pathways that regulate the actin cytoskeleton in dendritic spines . Cytoskelet . Hoboken 69 , 426 e 441 . Penzes , P . , Cahill , M . E . , Jones , K . A . , Srivastava , D . P . , 2008 . Convergent CaMK and RacGEF signals control dendritic structure and function . Trends Cell Biol . 18 , 405 e 413 . Penzes , P . , Rafalovich , I . , 2012 . Regulation of the actin cytoskeleton in dendritic spines . Adv . Exp . Med . Biol . 970 , 81 e 95 . Purcell , S . M . , Moran , J . L . , Fromer , M . , Ruderfer , D . , Solovieff , N . , Roussos , P . , O ' Dushlaine , C . , Chambert , K . , Bergen , S . E . , Kahler , A . , Duncan , L . , Stahl , E . , Genovese , G . , Fernandez , E . , Collins , M . O . , Komiyama , N . H . , Choudhary , J . S . , Magnusson , P . K . , Banks , E . , Shakir , K . , Garimella , K . , Fennell , T . , DePristo , M . , Grant , S . G . , Haggarty , S . J . , Gabriel , S . , Scolnick , E . M . , Lander , E . S . , Hultman , C . M . , Sullivan , P . F . , McCarroll , S . A . , Sklar , P . , 2014 . A polygenic burden of rare disruptive mutations in schizophrenia . Nature 506 , 185 e 190 . Ribases , M . , Bosch , R . , Hervas , A . , Ramos - Quiroga , J . A . , Sanchez - Mora , C . , Bielsa , A . , Gastaminza , X . , Guijarro - Domingo , S . , Nogueira , M . , Gomez - Barros , N . , Kreiker , S . , Gross - Lesch , S . , Jacob , C . P . , Lesch , K . P . , Reif , A . , Johansson , S . , Plessen , K . J . , Knappskog , P . M . , Haavik , J . , Estivill , X . , Casas , M . , Bayes , M . , Cormand , B . , 2009 . Case - control study of six genes asymmetrically expressed in the two cerebral hemispheres : association of BAIAP2 with attention - de ﬁ cit / hyperactivity disorder . Biol . Psychiatry 66 , 926 e 934 . Rinaldi , T . , Kulangara , K . , Antoniello , K . , Markram , H . , 2007 . Elevated NMDA receptor levels and enhanced postsynaptic long - term potentiation induced by prenatal exposure to valproic acid . Proc . Natl . Acad . Sci . U . S . A . 104 , 13501 e 13506 . Robens , J . M . , Yeow - Fong , L . , Ng , E . , Hall , C . , Manser , E . , 2010 . Regulation of IRSp53 - dependent ﬁ lopodial dynamics by antagonism between 14 - 3 - 3 binding and SH3 - mediated localization . Mol . Cell . Biol . 30 , 829 e 844 . Rosenmund , C . , Westbrook , G . L . , 1993 . Calcium - induced actin depolymerization reduces NMDA channel activity . Neuron 10 , 805 e 814 . Rossignol , D . A . , Frye , R . E . , 2014 . The use of medications approved for Alzheimer ' s disease in autism spectrum disorder : a systematic review . Front . Pediatr . 2 , 87 . Roussignol , G . , Ango , F . , Romorini , S . , Tu , J . C . , Sala , C . , Worley , P . F . , Bockaert , J . , Fagni , L . , 2005 . Shank expression is suf ﬁ cient to induce functional dendritic spine synapses in aspiny neurons . J . Neurosci . 25 , 3560 e 3570 . Roy , B . C . , Kakinuma , N . , Kiyama , R . , 2009 . Kank attenuates actin remodeling by preventing interaction between IRSp53 and Rac1 . J . Cell Biol . 184 , 253 e 267 . Rubenstein , J . L . , 2010 . Three hypotheses for developmental defects that may un - derlie some forms of autism spectrum disorder . Curr . Opin . Neurol . 23 , 118 e 123 . Rubenstein , J . L . , Merzenich , M . M . , 2003 . Model of autism : increased ratio of exci - tation / inhibition in key neural systems . Genes Brain Behav . 2 , 255 e 267 . Ryan , T . J . , Emes , R . D . , Grant , S . G . , Komiyama , N . H . , 2008 . Evolution of NMDA re - ceptor cytoplasmic interaction domains : implications for organisation of syn - aptic signalling complexes . BMC Neurosci . 9 , 6 . Safari , F . , Suetsugu , S . , 2012 . The BAR domain superfamily proteins from subcellular structures to human diseases . Membranes ( Basel ) 2 , 91 e 117 . Sala , C . , Piech , V . , Wilson , N . R . , Passafaro , M . , Liu , G . , Sheng , M . , 2001 . Regulation of dendritic spine morphology and synaptic function by Shank and Homer . Neuron 31 , 115 e 130 . Sala , C . , Segal , M . , 2014 . Dendritic spines : the locus of structural and functional plasticity . Physiol . Rev . 94 , 141 e 188 . Sanda , M . , Kamata , A . , Katsumata , O . , Fukunaga , K . , Watanabe , M . , Kondo , H . , Sakagami , H . , 2009 . The postsynaptic density protein , IQ - ArfGEF / BRAG1 , can interact with IRSp53 through its proline - rich sequence . Brain Res . 1251 , 7 e 15 . Saneyoshi , T . , Hayashi , Y . , 2012 . The Ca2 þ and Rho GTPase signaling pathways underlying activity - dependent actin remodeling at dendritic spines . Cytoskel - eton ( Hoboken ) 69 , 545 e 554 . Sani , G . , Serra , G . , Kotzalidis , G . D . , Romano , S . , Tamorri , S . M . , Manfredi , G . , Caloro , M . , Telesforo , C . L . , Caltagirone , S . S . , Panaccione , I . , Simonetti , A . , Demontis , F . , Serra , G . , Girardi , P . , 2012 . The role of memantine in the treatment of psychiatric disorders other than the dementias : a review of current preclinical and clinical evidence . CNS Drugs 26 , 663 e 690 . Sanz - Clemente , A . , Nicoll , R . A . , Roche , K . W . , 2013 . Diversity in NMDA receptor composition : many regulators , many consequences . Neuroscientist 19 , 62 e 75 . Sato , D . , Lionel , A . C . , Leblond , C . S . , Prasad , A . , Pinto , D . , Walker , S . , O ' Connor , I . , Russell , C . , Drmic , I . E . , Hamdan , F . F . , Michaud , J . L . , Endris , V . , Roeth , R . , Delorme , R . , Huguet , G . , Leboyer , M . , Rastam , M . , Gillberg , C . , Lathrop , M . , Stavropoulos , D . J . , Anagnostou , E . , Weksberg , R . , Fombonne , E . , Zwaigenbaum , L . , Fernandez , B . A . , Roberts , W . , Rappold , G . A . , Marshall , C . R . , Bourgeron , T . , Szatmari , P . , Scherer , S . W . , 2012 . SHANK1 deletions in males with autism spectrum disorder . Am . J . Hum . Genet . 90 , 879 e 887 . Sawallisch , C . , Berhorster , K . , Disanza , A . , Mantoani , S . , Kintscher , M . , Stoenica , L . , Dityatev , A . , Sieber , S . , Kindler , S . , Morellini , F . , Schweizer , M . , Boeckers , T . M . , Korte , M . , Scita , G . , Kreienkamp , H . J . , 2009 . The insulin receptor substrate of 53 kDa ( IRSp53 ) limits hippocampal synaptic plasticity . J . Biol . Chem . 284 , 9225 e 9236 . Scita , G . , Confalonieri , S . , Lappalainen , P . , Suetsugu , S . , 2008 . IRSp53 : crossing the road of membrane and actin dynamics in the formation of membrane pro - trusions . Trends Cell Biol . 18 , 52 e 60 . Sekerkova , G . , Loomis , P . A . , Changyaleket , B . , Zheng , L . , Eytan , R . , Chen , B . , Mugnaini , E . , Bartles , J . R . , 2003 . Novel espin actin - bundling proteins are local - ized to Purkinje cell dendritic spines and bind the Src homology 3 adapter protein insulin receptor substrate p53 . J . Neurosci . 23 , 1310 e 1319 . Sekerkova , G . , Richter , C . P . , Bartles , J . R . , 2011 . Roles of the espin actin - bundling proteins in the morphogenesis and stabilization of hair cell stereocilia revealed in CBA / CaJ congenic jerker mice . PLoS Genet . 7 , e1002032 . Selig , D . K . , Hjelmstad , G . O . , Herron , C . , Nicoll , R . A . , Malenka , R . C . , 1995 . Independent mechanisms for long - term depression of AMPA and NMDA responses . Neuron 15 , 417 e 426 . Shen , Y . , Peterson , A . S . , 2009 . Atrophins ' emerging roles in development and neurodegenerative disease . Cell . Mol . Life Sci . 66 , 437 e 446 . Sheng , M . , Hoogenraad , C . C . , 2007 . The postsynaptic architecture of excitatory synapses : a more quantitative view . Annu . Rev . Biochem . 76 , 823 e 847 . Sheng , M . , Kim , E . , 2011 . The postsynaptic organization of synapses . Cold Spring Harb . Perspect . Biol . 3 . Shim , S . S . , Nadeem , R . , 2014 . Are NMDA receptor antagonists bene ﬁ cial in the treatment of schizophrenia ? J . Psychiatr . Res . 51 , 19 e 20 . Shinohara , R . , Thumkeo , D . , Kamijo , H . , Kaneko , N . , Sawamoto , K . , Watanabe , K . , Takebayashi , H . , Kiyonari , H . , Ishizaki , T . , Furuyashiki , T . , Narumiya , S . , 2012 . A role for mDia , a Rho - regulated actin nucleator , in tangential migration of interneuron precursors . Nat . Neurosci . 15 ( 373 e 380 ) , S371 e S372 . Shoubridge , C . , Walikonis , R . S . , Gecz , J . , Harvey , R . J . , 2010 . Subtle functional defects in the Arf - speci ﬁ c guanine nucleotide exchange factor IQSEC2 cause non - syndromic X - linked intellectual disability . Small GTPases 1 , 98 e 103 . Soderling , S . H . , Guire , E . S . , Kaech , S . , White , J . , Zhang , F . , Schutz , K . , Langeberg , L . K . , Banker , G . , Raber , J . , Scott , J . D . , 2007 . A WAVE - 1 and WRP signaling complex regulates spine density , synaptic plasticity , and memory . J . Neurosci . 27 , 355 e 365 . Soderling , S . H . , Scott , J . D . , 2006 . WAVE signalling : from biochemistry to biology . Biochem . Soc . Trans . 34 , 73 e 76 . Soltau , M . , Berhorster , K . , Kindler , S . , Buck , F . , Richter , D . , Kreienkamp , H . J . , 2004 . Insulin receptor substrate of 53 kDa links postsynaptic shank to PSD - 95 . J . Neurochem . 90 , 659 e 665 . Soltau , M . , Richter , D . , Kreienkamp , H . J . , 2002 . The insulin receptor substrate IRSp53 J . Kang et al . / Neuropharmacology 100 ( 2016 ) 27 e 39 38 links postsynaptic shank1 to the small g - protein cdc42 . Mol . Cell . Neurosci . 21 , 575 e 583 . Stamatakou , E . , Marzo , A . , Gibb , A . , Salinas , P . C . , 2013 . Activity - dependent spine morphogenesis : a role for the actin - capping protein Eps8 . J . Neurosci . 33 , 2661 e 2670 . Stephenson , J . R . , Purcell , R . H . , Hall , R . A . , 2014 . The BAI subfamily of adhesion GPCRs : synaptic regulation and beyond . Trends Pharmacol . Sci . 35 , 208 e 215 . Suetsugu , S . , Hattori , M . , Miki , H . , Tezuka , T . , Yamamoto , T . , Mikoshiba , K . , Takenawa , T . , 2002 . Sustained activation of N - WASP through phosphorylation is essential for neurite extension . Dev . Cell 3 , 645 e 658 . Suetsugu , S . , Murayama , K . , Sakamoto , A . , Hanawa - Suetsugu , K . , Seto , A . , Oikawa , T . , Mishima , C . , Shirouzu , M . , Takenawa , T . , Yokoyama , S . , 2006 . The RAC binding domain / IRSp53 - MIM homology domain of IRSp53 induces RAC - dependent membrane deformation . J . Biol . Chem . 281 , 35347 e 35358 . Suetsugu , S . , Toyooka , K . , Senju , Y . , 2010 . Subcellular membrane curvature medi - ated by the BAR domain superfamily proteins . Semin . Cell Dev . Biol . 21 , 340 e 349 . Tada , T . , Sheng , M . , 2006 . Molecular mechanisms of dendritic spine morphogenesis . Curr . Opin . Neurobiol . 16 , 95 e 101 . Teodorof , C . , Bae , J . I . , Kim , S . M . , Oh , H . J . , Kang , Y . S . , Choi , J . , Chun , J . S . , Song , W . K . , 2009 . SPIN90 - IRSp53 complex participates in Rac - induced membrane ruf ﬂ ing . Exp . Cell Res . 315 , 2410 e 2419 . Thomas , S . J . , Grossberg , G . T . , 2009 . Memantine : a review of studies into its safety and ef ﬁ cacy in treating Alzheimer ' s disease and other dementias . Clin . Interv . Aging 4 , 367 e 377 . Tolias , K . F . , Bikoff , J . B . , Burette , A . , Paradis , S . , Harrar , D . , Tavazoie , S . , Weinberg , R . J . , Greenberg , M . E . , 2005 . The Rac1 - GEF Tiam1 couples the NMDA receptor to the activity - dependent development of dendritic arbors and spines . Neuron 45 , 525 e 538 . Tolias , K . F . , Bikoff , J . B . , Kane , C . G . , Tolias , C . S . , Hu , L . , Greenberg , M . E . , 2007 . The Rac1 guanine nucleotide exchange factor Tiam1 mediates EphB receptor - dependent dendritic spine development . Proc . Natl . Acad . Sci . U . S . A . 104 , 7265 e 7270 . Tolias , K . F . , Duman , J . G . , Um , K . , 2011 . Control of synapse development and plasticity by Rho GTPase regulatory proteins . Prog . Neurobiol . 94 , 133 e 148 . Toma , C . , Hervas , A . , Balmana , N . , Vilella , E . , Aguilera , F . , Cusco , I . , del Campo , M . , Caballero , R . , De Diego - Otero , Y . , Ribases , M . , Cormand , B . , Bayes , M . , 2011 . As - sociation study of six candidate genes asymmetrically expressed in the two cerebral hemispheres suggests the involvement of BAIAP2 in autism . J . Psychiatr . Res . 45 , 280 e 282 . Toma , C . , Torrico , B . , Hervas , A . , Valdes - Mas , R . , Tristan - Noguero , A . , Padillo , V . , Maristany , M . , Salgado , M . , Arenas , C . , Puente , X . S . , Bayes , M . , Cormand , B . , 2013 . Exome sequencing in multiplex autism families suggests a major role for het - erozygous truncating mutations . Mol . Psychiatry 9 ( 7 ) , 784 e 790 . Tseng , C . Y . , Firestein , B . L . , 2011 . The role of PSD - 95 and cypin in morphological changes in dendrites following sublethal NMDA exposure . J . Neurosci . 31 , 15468 e 15480 . Tsuji , S . , 2012 . Dentatorubral - pallidoluysian atrophy . Handb . Clin . Neurol . 103 , 587 e 594 . Vanzo , R . J . , Martin , M . M . , Sdano , M . R . , South , S . T . , 2013 . Familial KANK1 deletion that does not follow expected imprinting pattern . Eur . J . Med . Genet . 56 , 256 e 259 . Wagner , A . R . , Luan , Q . , Liu , S . L . , Nolen , B . J . , 2013 . Dip1 de ﬁ nes a class of Arp2 / 3 complex activators that function without preformed actin ﬁ laments . Curr . Biol . 23 , 1990 e 1998 . Wegner , A . M . , Nebhan , C . A . , Hu , L . , Majumdar , D . , Meier , K . M . , Weaver , A . M . , Webb , D . J . , 2008 . N - wasp and the arp2 / 3 complex are critical regulators of actin in the development of dendritic spines and synapses . J . Biol . Chem . 283 , 15912 e 15920 . Won , H . , Lee , H . R . , Gee , H . Y . , Mah , W . , Kim , J . I . , Lee , J . , Ha , S . , Chung , C . , Jung , E . S . , Cho , Y . S . , Park , S . G . , Lee , J . S . , Lee , K . , Kim , D . , Bae , Y . C . , Kaang , B . K . , Lee , M . G . , Kim , E . , 2012 . Autistic - like social behaviour in Shank2 - mutant mice improved by restoring NMDA receptor function . Nature 486 , 261 e 265 . Wyszynski , M . , Lin , J . , Rao , A . , Nigh , E . , Beggs , A . H . , Craig , A . M . , Sheng , M . , 1997 . Competitive binding of alpha - actinin and calmodulin to the NMDA receptor . Nature 385 , 439 e 442 . Yamagishi , A . , Masuda , M . , Ohki , T . , Onishi , H . , Mochizuki , N . , 2004 . A novel actin bundling / ﬁ lopodium - forming domain conserved in insulin receptor tyrosine kinase substrate p53 and missing in metastasis protein . J . Biol . Chem . 279 , 14929 e 14936 . Yanagida - Asanuma , E . , Asanuma , K . , Kim , K . , Donnelly , M . , Young Choi , H . , Hyung Chang , J . , Suetsugu , S . , Tomino , Y . , Takenawa , T . , Faul , C . , Mundel , P . , 2007 . Synaptopodin protects against proteinuria by disrupting Cdc42 : IRSp53 : Mena signaling complexes in kidney podocytes . Am . J . Pathol . 171 , 415 e 427 . Yeh , T . C . , Ogawa , W . , Danielsen , A . G . , Roth , R . A . , 1996 . Characterization and cloning of a 58 / 53 - kDa substrate of the insulin receptor tyrosine kinase . J . Biol . Chem . 271 , 2921 e 2928 . Yizhar , O . , Fenno , L . E . , Prigge , M . , Schneider , F . , Davidson , T . J . , O ' Shea , D . J . , Sohal , V . S . , Goshen , I . , Finkelstein , J . , Paz , J . T . , Stehfest , K . , Fudim , R . , Ramakrishnan , C . , Huguenard , J . R . , Hegemann , P . , Deisseroth , K . , 2011 . Neocortical excitation / in - hibition balance in information processing and social dysfunction . Nature 477 , 171 e 178 . J . Kang et al . / Neuropharmacology 100 ( 2016 ) 27 e 39 39